US20010039445A1 - Stent delivery system and method of use - Google Patents

Stent delivery system and method of use Download PDF

Info

Publication number
US20010039445A1
US20010039445A1 US09/891,663 US89166301A US2001039445A1 US 20010039445 A1 US20010039445 A1 US 20010039445A1 US 89166301 A US89166301 A US 89166301A US 2001039445 A1 US2001039445 A1 US 2001039445A1
Authority
US
United States
Prior art keywords
myocardium
distal end
guidewire
catheter
delivery catheter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/891,663
Inventor
Todd Hall
Greg Furnish
Simon Furnish
Scott Wolf
Peter Wilk
David Phelps
Vincent Pompili
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Percardia Inc
Original Assignee
Percardia Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Percardia Inc filed Critical Percardia Inc
Priority to US09/891,663 priority Critical patent/US20010039445A1/en
Publication of US20010039445A1 publication Critical patent/US20010039445A1/en
Priority to US10/625,536 priority patent/US20040186507A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2/958Inflatable balloons for placing stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/24Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2493Transmyocardial revascularisation [TMR] devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238Type of minimally invasive operation
    • A61B2017/00243Type of minimally invasive operation cardiac
    • A61B2017/00247Making holes in the wall of the heart, e.g. laser Myocardial revascularization
    • A61B2017/00252Making holes in the wall of the heart, e.g. laser Myocardial revascularization for by-pass connections, i.e. connections from heart chamber to blood vessel or from blood vessel to blood vessel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00345Vascular system
    • A61B2018/00351Heart
    • A61B2018/00392Transmyocardial revascularisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0082Catheter tip comprising a tool
    • A61M2025/0096Catheter tip comprising a tool being laterally outward extensions or tools, e.g. hooks or fibres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/01Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/0194Tunnelling catheters
    • A61M2025/0197Tunnelling catheters for creating an artificial passage within the body, e.g. in order to go around occlusions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1095Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation while the balloon is in an inflated state or in a deflated state, e.g. permanent by-pass within catheter shaft
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1006Balloons formed between concentric tubes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S623/00Prosthesis, i.e. artificial body members, parts thereof, or aids and accessories therefor
    • Y10S623/902Method of implanting
    • Y10S623/903Blood vessel

Definitions

  • the present invention relates to the delivery of a stent and other devices into the myocardium of a patient, and more particularly, to a stent delivery system to provide a bypass through the myocardium from the left ventricle into a coronary artery.
  • Coronary arteries as well as other vessels frequently become clogged with plaque that at the very least impairs the efficiency of the heart's pumping action and can lead to heart attack and death.
  • One conventional treatment for clogged coronary or other arteries is a bypass operation wherein one or more venous segments are inserted between the aorta and the coronary artery. The inserted venous segments or transplants act as a bypass of the clogged portion of the coronary artery and thus provide for a free or unobstructed flow of blood to the heart.
  • a new coronary artery bypass technique is disclosed in U.S. Pat. No. 5,429,144. That technique utilizes a stent made of a biocompatible material and comprises steps of moving the stent in a collapsed configuration through a blood vessel of a patient's vascular system to the patient's heart, inserting the stent in the patient's myocardium, and upon disposition of the stent in the myocardium, expanding the stent from the collapsed configuration to a substantially tubular expanded configuration so that a blood flow path is formed at least partially through the myocardium.
  • a method and apparatus for delivering guidewires, stents and other devices into the myocardium In particular, what is needed is a delivery system that can deliver these devices at an angled bend for transverse insertion into the myocardium. Moreover, what is needed is a delivery method and apparatus for advancing a delivery catheter to a puncture site in a coronary vessel when the blockage in the vessel is too large to permit passage of a catheter therethrough. What is also needed is a method and apparatus for advancement of a stent, dilation catheter or other device into and through the myocardium.
  • the present invention addresses the above needs by providing various methods and apparatuses for delivering stents and other devices into the myocardium of a patient.
  • One preferred stent delivery system provides access to the insertion site in the myocardium by advancing a delivery catheter through a blockage in a coronary artery, or around the blockage through a coronary vein or through a channel or tunnel formed around the blockage.
  • an angled bend is created in the catheter by actuating expandable steering guides mounted to the catheter which cooperate with the walls of the blood vessel to cause the catheter to turn.
  • a guidewire is advanced through the delivery catheter and into the myocardium.
  • a tip-deflecting pull wire extends from the distal end of the delivery catheter which may be actuated to turn towards and then inserted into the myocardium.
  • an exit port facing the insertion site is provided within the catheter or a balloon mounted on the catheter so that a guidewire may be directed through a lumen and out the exit port into the myocardium.
  • a guidewire is delivered into the patient such that the proximal end of the guidewire extends out of the patient, while the distal end of the guidewire is positioned adjacent the myocardium.
  • the distal end of the guidewire is inserted into the myocardium, and the guidewire is then anchored to the myocardium.
  • An introducer catheter carrying a medical device is advanced over the guidewire to deliver the device into the myocardium.
  • a method for delivering a stent into the myocardium to bypass a blockage formed in a coronary artery is provided.
  • a channel is created from a position proximal to the blockage in the coronary artery to a position distal to the blockage in the coronary artery.
  • a guidewire is advanced through the channel until a distal end of the guidewire is adjacent the myocardium.
  • the guidewire is inserted into the myocardium, and a stent is advanced over the guidewire into the myocardium.
  • a method for creating a bypass through the myocardium of a patient to bypass a blockage formed in a coronary artery.
  • a first tunnel is created through the myocardium having a proximal end and a distal end.
  • the proximal end of the tunnel opens into the coronary artery proximal to the blockage.
  • the distal end of the tunnel is positioned within the myocardium.
  • a second tunnel is created through the myocardium, the second tunnel having a first branch extending from the distal end of the first tunnel and opening into the coronary artery at a position distal to the blockage.
  • a second branch of the second tunnel extends from the distal end of the first channel and opens into the left ventricle.
  • a stent is disposed in the second tunnel to provide a myocardial passageway therethrough.
  • a delivery catheter in another aspect of the present invention, comprises an elongate tubular body having a proximal end and a distal end and a lumen extending therethrough.
  • a first steering member is mounted on the distal end of the tubular body, and a second steering member is mounted on the distal end of the tubular body at a position distal to that of the anchoring member.
  • a method for turning a distal end of a catheter within a body lumen comprises an elongate tubular body having a proximal end and a distal end.
  • An anchoring member mounted to the distal end is actuated to secure the catheter against the body lumen.
  • a steering member is mounted to the distal end of the of the guidewire at a position distal to that of the anchoring member. When actuated, the steering member cooperates with the body lumen to turn the distal end of the catheter.
  • a method for delivering a medical device to a delivery site within a patient.
  • This method comprises providing a delivery catheter having a proximal end and a distal end and a lumen extending therethrough into a body lumen of the patient.
  • the delivery catheter is secured within the body lumen.
  • the distal end of the catheter is turned by actuating a steering member mounted on the distal end of the catheter which pushes off against a wall of the body lumen.
  • the medical device is advanced through the lumen of the delivery catheter and out the distal end.
  • a method for delivering a stent into the myocardium of a patient is provided.
  • a delivery catheter is advanced into the vasculature of the patient, the delivery catheter having a proximal end and a distal end and a lumen extending therethrough, until the distal end is adjacent the myocardium.
  • a pull wire extending from the distal end of the delivery catheter is actuated to turn the pull wire toward the myocardium.
  • the pull wire is advanced from the distal end of the delivery catheter into the myocardium.
  • the stent is delivered over the pull wire into the myocardium.
  • a method for delivering a stent into the myocardium of a patient is provided.
  • a delivery catheter is advanced into the vasculature of the patient, the catheter having a proximal end and a distal end and a lumen extending from the proximal end to a side port near the distal end, until the side port faces the myocardium.
  • a guidewire having a proximal end and a distal end is inserted into the lumen. The distal end of the guidewire is advanced through the lumen and out the side port. The guidewire punctures into the myocardium, and the stent is delivered over the guidewire into the myocardium.
  • a method for delivering a stent into the myocardium of a patient is provided.
  • a delivery catheter is advanced into the vasculature of a patient, the catheter having a proximal end and a distal end, until the distal end is adjacent the myocardium.
  • An anchoring member mounted on the distal end of the catheter is expanded to secure the delivery catheter within the vasculature.
  • a guidewire having a proximal end and a distal end is inserted through a lumen in the expanded anchoring member, the lumen extending from a proximal end of the anchoring member to a side port facing the myocardium, so that the distal end of the guidewire exits through the side port.
  • the guidewire punctures into the myocardium, and the stent is advanced over the guidewire into the myocardium.
  • a delivery catheter in another aspect of the present invention, comprises an elongate body having a proximal end and a distal end.
  • An expandable member is mounted on the distal end of the tubular body, the expandable member having a proximal end and a distal end and an exterior surface.
  • a guide lumen extends from the proximal end of the balloon to a side port on the exterior surface of the expandable member for directing a medical device therethrough.
  • a method for treating an aneurysm is provided.
  • a catheter having a proximal end and a distal end is advanced to the site of the aneurysm.
  • An expandable member mounted on the distal end of the catheter is actuated to substantially enclose the aneurysm.
  • An embolic element is inserted through a lumen in the expandable member into the aneurysm.
  • a method for delivering a medical device into a body tissue of a patient comprises inserting a guidewire having a proximal end and a distal end into the myocardium from a coronary blood vessel.
  • the guidewire is anchored to the body tissue, and the medical device is pushed over the guidewire into the body tissue.
  • the proximal end of the guidewire is correspondingly pulled proximally while the medical device is pushed distally in order to assist advancing the medical device through the body tissue.
  • a delivery system for directing medical treatment at least partially into the myocardium comprises a guidewire having a proximal end and a distal end, means for turning the distal end of the guidewire toward the myocardium, means for anchoring the guidewire to the myocardium, and a catheter carrying the medical treatment having a lumen extending therethrough for receiving the guidewire and advancing the catheter into the myocardium.
  • a method for delivering a stent into the myocardium of a patient to bypass a blockage formed in a coronary artery comprises advancing a catheter having a proximal end and a distal end and a lumen extending at least partially therethrough from the proximal end to a distal opening through the coronary artery of the patient until the distal opening is past the blockage.
  • the catheter is turned so that the distal opening faces the myocardium.
  • a wire having a proximal end and a distal end is extended through the distal opening such that the distal end punctures into the myocardium.
  • the distal end of the wire is anchored to the myocardium.
  • a dilation catheter is delivered over the wire, the catheter carrying a dilation balloon on a distal end thereof, until the balloon is within the myocardium.
  • the dilation balloon is inflated to create an opening in the myocardium.
  • the dilation balloon is then deflated and the dilation catheter removed from the wire.
  • a stent introducer catheter is delivered over the wire, the stent introducer catheter carrying a stent on a distal end thereof, until the stent is located within the opening in the myocardium.
  • the stent is deployed within the opening in the myocardium.
  • a method for delivering medical treatment into the myocardium of a patient is provided.
  • a tubular wire is delivered into the patient, the wire having a lumen extending therethrough.
  • the wire once delivered has a proximal end extending out of the patient and a distal end positioned adjacent the myocardium.
  • Means for turning the distal end of the wire towards the myocardium are provided. Then, the distal end of the wire is inserted into the myocardium. Medical treatment is delivered through the lumen in the wire into the myocardium.
  • FIG. 1A is a schematic, cross-sectional view of a human heart, showing a stent in the myocardium of the heart for forming a bypass shunt between the left ventricle and a coronary artery.
  • FIG. 1B is an enlarged view of the bypass shunt of FIG. 1A.
  • FIG. 2 is a schematic, partial cross-sectional view of a human heart, showing a stent extending partially into the myocardium from the left ventricle.
  • FIG. 3A is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a delivery catheter being advanced through a blockage in the coronary artery.
  • FIG. 3B is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a delivery catheter being advanced into the left ventricle.
  • FIG. 4A is a schematic side view of a venous access route through a patient's heart.
  • FIG. 4B is a schematic, partial cross-sectional view of the venous access route of FIG. 4A between a coronary vein and a coronary artery, showing a delivery catheter being advanced through the coronary vein into the coronary artery.
  • FIG. 5 is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a tunnel formed through the myocardium to bypass a blockage in the coronary artery.
  • FIG. 6 is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a delivery catheter being advanced through a tunnel formed through the myocardium.
  • FIG. 7 is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a Y-shaped tunnel formed through the myocardium to bypass a blockage in the coronary artery.
  • FIG. 8 is a partial cross-sectional view of the Y-shaped tunnel of FIG. 7, showing a stent provided therein.
  • FIG. 9 is a side view of a delivery catheter carrying two uninflated steering balloons in a blocked coronary artery, with the artery shown partially cut away.
  • FIG. 10 is a side view of the delivery catheter of FIG. 9, showing the two balloons partially inflated.
  • FIG. 11 is a side view of the delivery catheter of FIG. 9, showing the two balloons fully inflated and a guidewire extending from the distal end of the delivery catheter.
  • FIG. 12 is a side view of a delivery catheter with a tip deflecting wire in a blocked coronary artery, with the artery shown partially cut away.
  • FIG. 13A is a side view of a delivery catheter having a side port proximal to an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away.
  • FIG. 13B is a cross-sectional view of the delivery catheter of FIG. 13A, further showing a guidewire extending therethrough.
  • FIG. 14A is a side view of a delivery catheter having a side port distal to an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away.
  • FIG. 14B is a cross-sectional view of the delivery catheter of FIG. 14A, further showing a guidewire extending therethrough.
  • FIG. 15A is a side view of a delivery catheter having a side port within an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away.
  • FIG. 15B is a cross-sectional view of the delivery catheter of FIG. 15A, further showing a guidewire extending through the balloon.
  • FIG. 15C is a side view of an alternative embodiment of a delivery catheter having a side port within an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away.
  • FIG. 15D is a cross-sectional view of the delivery catheter of FIG. 15C, further showing a guidewire extending through the balloon.
  • FIG. 16 is a side view of a delivery catheter having a side port within an inflatable balloon used for treating an aneurysm in a blood vessel, with the vessel shown partially cut away.
  • FIG. 17 is a side view of an anchoring guidewire extending through the myocardium, with the myocardium shown partially cut away.
  • FIG. 18A is a side view of a guidewire carrying an inflatable balloon on its distal end extending through the myocardium, with the myocardium shown partially cut away.
  • FIG. 18B is a side view of the guidewire of FIG. 18A, showing the balloon inflated to anchor the guidewire against the myocardium.
  • FIGS. 19 A- 19 C are side views of an alternative embodiment of a guidewire anchored to the inner wall of the myocardium, with the myocardium shown partially cut away.
  • FIG. 20 is a side view of a dilation catheter in a coronary artery advanced over a guidewire extending into the myocardium, with the artery and the myocardium shown partially cut away.
  • FIG. 21 is a side view of the dilation catheter of FIG. 20 advanced into the myocardium.
  • FIG. 22 is a side view of a stent introducer catheter in a coronary artery advanced over a guidewire extending into the myocardium, with the artery and myocardium shown partially cut away.
  • FIG. 23 is a side view of the stent introducer catheter of FIG. 22 advanced into the myocardium.
  • FIG. 24 is a side view of a drug delivery wire advanced through a coronary artery into the myocardium, with the artery and the myocardium shown partially cut away.
  • the preferred embodiments described hereinbelow depict methods and apparatuses for delivering a stent into the myocardium to create a passageway between the left ventricle and coronary artery. It should be appreciated, however, that these embodiments may also be applied to the delivery of stents and other medical devices into other body tissues and vessels, and are particularly applicable for delivering devices at an angled bend relative to the axis of blood flow. In addition, the delivery methods and apparatuses described herein pertain to the placement of stents and other devices partially through the myocardium, as well as for drug delivery and similar applications.
  • a coronary artery bypass is accomplished by disposing a stent 10 in a heart wall or myocardium MYO of a patient's heart PH.
  • Stent 10 preferably extends from the left ventricle LV of heart PH to a clogged coronary artery CA at a point downstream of a blockage BL to create a shunt 12 therethrough.
  • Stent 10 is preferably made of a biocompatible material such as stainless steel or nitinol, although other materials such as Ti, Ti alloys, Ni alloys, Co alloys and biocompatible polymers may also be used.
  • Stent 10 preferably has a one way valve 14 to allow blood to flow from the left ventricle LV to the coronary artery CA.
  • the stent 10 may elastically deform under the contractive pressure of the heart muscle during systole, the stent remains open to allow blood to pass from the patient's left ventricle LV into the coronary artery CA.
  • the blood pumped into coronary artery through shunt 12 is blocked by one-way valve 14 from returning to left ventricle LV.
  • Other types of stents may also be used in accordance with the preferred embodiments described herein.
  • FIG. 2 illustrates another application for which it is desirable to dispose a stent into the myocardium of a patient.
  • a stent 10 is provided partially through the myocardium MYO from the left ventricle LV.
  • the stent 10 guides blood directly into the myocardium MYO from the left ventricle to replenish oxygen-deprived heart muscle. Further details are disclosed in the above-referenced U.S. Pat. No. 5,429,144.
  • Other applications providing a stent in the myocardium, extending either partially or entirely therethrough and accessed from either the coronary artery or the left ventricle, are also contemplated by the present invention.
  • the suitable delivery system (1) provides access to the insertion site adjacent the myocardium; (2) creates an angled bend for transverse insertion of devices into the myocardium; and (3) directs devices into the myocardium for creation of the myocardial passageway.
  • the delivery system described herein preferably comprises one or more catheters or guidewires inserted percutaneously into the body, such as through the femoral artery and advanced in the patient's vasculature through the aorta AO, shown in FIG. 1A. It should be appreciated that the percutaneous approach is not essential to achieve many of the objects of the invention, and therefore, an open-chest or other approach may also be used.
  • an exemplary delivery catheter or guidewire 20 which has been advanced percutaneously through the femoral artery and through aorta AO is advanced through the blockage BL in the coronary artery CA.
  • the distal tip 22 of the catheter is delivered past the blockage so that it is positioned adjacent to a desired insertion point into the myocardium MYO.
  • FIG. 3B shows an alternative access method wherein the catheter 20 is delivered to a position adjacent the myocardium through the left ventricle LV.
  • FIGS. 4A and 4B depict an alternative access route used when a blockage in the coronary artery is too large for the catheter to be passed therethrough.
  • a delivery catheter 20 enters the body through an access point preferably in the femoral vein (not shown). The catheter is advanced up the vein to the vena cava VC and into the right atrium RA, as shown in FIG. 4A. Then, the catheter 20 is directed into the coronary sinus CS, and then to the coronary vein CV which runs adjacent to the coronary artery CA.
  • the delivery catheter 20 is inserted through the vessel wall VW separating the coronary vein CV from the coronary artery CA.
  • Steering of catheter 20 between coronary vein CV and coronary artery CA may be accomplished using the methods and apparatus for turning catheters discussed in further detail below, or other suitable methods.
  • the delivery catheter is turned toward the myocardium MYO either for insertion into the myocardium or for directing a guidewire to puncture therethrough.
  • Access to the insertion point may also be accomplished by steering the delivery catheter through the coronary artery CA to a point proximal to the blockage, directing the catheter into the coronary vein to bypass the blockage, and reinserting the catheter from the coronary vein into the coronary artery past the blockage, as shown in FIG. 4B.
  • An alternative method of accessing the myocardium MYO when the blockage BL is too large to pass a catheter therethrough employs creating a channel around the blockage.
  • a tunnel 24 is created from the coronary artery CA into the myocardium MYO at a point proximal to the blockage BL.
  • the tunnel may be created using radiation, lasers, or a surgical drill, or any other suitable methods for creating a tunnel.
  • the tunnel 24 extends underneath the blockage BL and connects with the coronary artery CA at a point distal to the blockage BL. As shown in FIG.
  • a delivery catheter 20 is advanced through the coronary artery CA, into the tunnel 24 , and back into the coronary artery CA past the blockage BL. It will be appreciated that other methods for diverting a delivery catheter around a blockage may be used, such as directing the catheter through a shunt into the pericardial space outside the coronary artery.
  • tunnel 24 shown in FIG. 6 is described as providing access to a myocardial insertion point for a coronary bypass, it should also be appreciated that this tunneling technique may be useful for obliteration of the blockage BL.
  • conventional methods for ablating a blockage only permit access to the blockage from one side.
  • a blockage BL can be treated not only from its proximal end, but also from its distal end simultaneously.
  • a tunnel is created through the myocardium MYO from a point proximal to a blockage in the coronary artery into the left ventricle.
  • a first tunnel 26 is formed proximally of the blockage BL extending into the myocardium MYO beneath the blockage BL.
  • the tunnel 26 has a proximal end 28 which opens into the coronary artery CA proximal to the blockage BL, and a distal end 30 within the myocardium MYO beneath the blockage BL.
  • a second tunnel 32 extends from the distal end 30 of the first tunnel, with a first branch 34 opening a channel to the coronary artery CA past the location of the blockage BL.
  • a second branch 36 of the second tunnel 32 extends downward from the distal end 30 and opens into the left ventricle LV. As illustrated in FIG. 7, a substantially Y-shaped passageway is thereby created through the myocardium MYO to bypass the blockage BL.
  • one or more stents 10 are provided in the second tunnel 32 extending between the left ventricle LV and the coronary artery CA.
  • This stent 10 opens the myocardial passageway which provides the bypass past blockage BL.
  • Positioning of stent 10 in the tunnel 32 is preferably accomplished by advancing a guidewire through the first tunnel 26 and into each branch 34 and 36 of the second tunnel 32 , and then advancing the stent over the guidewire in the manner described below.
  • the tunnel 26 between the coronary artery CA and stent 14 is preferably closed at least at distal end 30 , and more preferably, also at proximal end 28 .
  • Closure of the tunnel may be accomplished by inserting plugs or other blocking means 38 , or by sealing the tunnel with sutures or similar methods.
  • Other suitable closure means include occlusion coils and balloons, adhesives such as cyanoacrylate, and plugs such as sold under the trade name GELFOAM.
  • the tunnel may be closed due to the natural contraction of the openings 28 and 30 over time.
  • an appropriate delivery system is brought to the site.
  • the preferred embodiments described hereinbelow are directed to a delivery system for inserting stents and other medical devices into the myocardium at an angle relative to the axis of blood flow. It should be appreciated that the angle of insertion may be adjusted between 0 and 180 degrees depending on the desired application.
  • the delivery systems below describe insertion of devices into the myocardium, these systems also enable angled delivery of medical devices into and through other body lumens and tissues.
  • the stent delivery system comprises a catheter which creates an angled bend for insertion of devices into the myocardium MYO.
  • FIG. 9 illustrates a delivery catheter 40 which has been advanced into the coronary artery CA past the blockage BL.
  • Catheter 40 is an elongate tubular body 42 having a lumen 44 (not shown) extending from a proximal end 46 (not shown) to a distal end 48 .
  • the catheter 40 is preferably formed from a flexible biocompatible material such as polymers, stainless steel or nitinol.
  • a steering member such as balloon 52
  • an anchoring member such as balloon 50
  • Balloons 50 and 52 are each preferably mounted on opposite sides of the catheter tubular body 42 , such that anchoring balloon 50 is mounted facing lower wall LW adjacent the myocardium MYO, and steering balloon 52 is mounted facing upper wall UW opposite lower wall LW.
  • the anchoring balloon 50 may be mounted concentrically around the tubular body 42 so that inflation of the balloon expands against both the upper and lower walls. It will be appreciated that other devices, such as filters, posts and other expandable members may be used for the anchoring and/or steering members.
  • the balloons 50 and 52 remain uninflated. As illustrated in FIG. 10, once the distal tip 48 of the catheter 40 is positioned adjacent the desired insertion site into the myocardium MYO, the balloons 50 and 52 are inflated. Inflation causes the balloons 50 and 52 to cooperate with the walls of the blood vessel to turn the distal end of the catheter. More particularly, in an intermediate state, anchoring balloon 50 inflates against the lower wall LW of the coronary artery CA, while steering balloon 40 presses against the upper wall UW.
  • anchoring balloon 50 acts to secure the tubular body 42 within the coronary artery CA.
  • Inflation of balloon 50 also preferably causes the catheter 40 to displace in a direction opposite lower wall LW, thereby placing the catheter into a better position for transverse insertion of the distal end 48 into the myocardium MYO.
  • Steering balloon 52 is further inflated, causing the distal tip 48 of the tubular body 32 to turn downward towards lower wall LW and myocardium MYO due to the resistance provided by upper wall UW against the balloon.
  • FIG. 11 also illustrates the effect that the dual balloon inflation may have on the upper and lower walls of the coronary artery CA.
  • catheter 40 Due to the turning action of catheter 40 caused by inflation of balloons 50 and 52 , as well as the bending of lower wall LW toward distal end 48 , once inflation of the balloons 50 and 52 is complete, the distal tip 48 of catheter 30 is positioned at a substantially transverse angle to the lower wall LW of the coronary artery CA and the myocardium MYO. From this position, the catheter 40 may serve as a guide for the delivery of devices used in creating a myocardial passageway. For example, as shown in FIG.
  • a puncture wire or guidewire 100 is advanced through the lumen 44 of tubular body 42 , and then ejected out the distal tip 48 of the catheter 40 to puncture the lower wall LW into the myocardium MYO.
  • FIG. 12 illustrates another embodiment for delivering devices transversely into the myocardium MYO of a patient's heart.
  • a catheter 54 is shown extending through the coronary artery CA past a blockage BL.
  • Catheter 54 comprises an elongate tubular body 56 with a lumen 58 (not shown) extending therethrough from a proximal end 60 (not shown) to a distal end 62 .
  • a tip-deflecting puncture wire or pull wire 64 extends from the distal end 62 of the catheter 54 .
  • the wire 64 is actuated at the proximal end (not shown) so that it deflects to form a near 90 degree angle relative to the catheter 54 .
  • the distal tip 66 of wire 64 is turned so that it is provided adjacent the myocardium MYO. This shape can be locked and the wire 64 is pushed forward through the coronary artery CA and into the wall of the myocardium MYO. As described in further detail below, with the wire 64 in place medical devices are delivered over the wire into the myocardium.
  • a delivery catheter is provided with a side port which allows a puncture wire to exit therethrough.
  • delivery catheter 70 comprises an elongate tubular body 72 having a proximal end 76 (not shown) and a distal end 78 and a lumen 74 (not shown) extending at least partially therethrough.
  • an expandable or anchoring member such as inflatable balloon 80 , which is inflated to maintain the position of the catheter 70 within the artery.
  • the balloon 80 is preferably a perfusion type balloon having a channel 86 to allow blood flow through the artery during the procedure.
  • filters or other devices which allow blood flow through the artery while anchoring the catheter 70 may also be utilized.
  • Perfusion may also be provided through a lumen in the tubular body 72 .
  • a distal opening or side port exit 82 is provided through the wall of tubular body 72 near the distal end of the catheter extending from lumen 74 .
  • the side port 82 may be located either proximal to the balloon 80 , as in FIG. 13A, or distal to the balloon 80 , as in FIG. 14A.
  • Catheter 70 is delivered through the vasculature until the side port exit 82 is past the location of the blockage BL. Prior to balloon inflation, the catheter 70 is turned about its longitudinal axis so that the opening 82 faces the myocardium.
  • FIGS. 13B and 14B illustrate the pathway for a guidewire 100 to pass through the lumen 74 of catheter 70 .
  • guidewire 100 extends through the lumen 74 toward the distal end 78 of the catheter. Proximal to balloon 80 , the lumen 74 turns downward toward side port exit 82 . Thus, before guidewire 100 reaches the proximal end of balloon 80 , the guidewire 100 is directed out of the side port 82 toward the lower wall LW of the coronary artery CA.
  • a second lumen 84 is also provided within catheter 70 to direct inflation fluid to balloon 80 .
  • FIG. 14B shows substantially the same configuration except that the lumen 74 extends through the balloon 80 such that the side port exit 82 is located distal to the balloon 80 .
  • Guidewire 100 therefore extends through lumen 74 and out side port exit 82 toward the lower wall LW.
  • a second lumen 84 is provided through tubular body 72 to direct inflation fluid into the balloon 80 .
  • the side port 82 is located on an exterior surface of the balloon 80 .
  • balloon 80 is inflated.
  • balloon 80 preferably comprises a perfusion channel 86 extending from the proximal end to the distal end of the balloon 80 to allow blood to flow through the vessel.
  • a lumen 74 is provided through the catheter 70 which extends into balloon 80 and turns downward into side port exit 82 .
  • the catheter 70 also has a lumen 84 for inflation of balloon 80 .
  • Guidewire 100 is advanced through lumen 74 and out side port exit 82 into the myocardium MYO.
  • FIGS. 15C and 15D illustrate yet another embodiment of a delivery catheter with a side port exit.
  • the catheter 70 comprises an elongate tubular body 72 having a lumen 74 extending from a proximal end 76 (not shown) to distal end 78 .
  • This lumen 74 is in fluid communication with balloon 80 to provide inflation of the balloon.
  • balloon 80 When inflated, balloon 80 has a perfusion lumen 86 which allows blood to perfuse therethrough.
  • the balloon 80 also has a guide lumen 88 extending therethrough which, when inflated, extends from a proximal end of the balloon to the lower wall LW.
  • a guidewire 100 may then be inserted through the guide lumen 88 and out side port exit 82 into the myocardium MYO.
  • FIGS. 15 A- 15 D are useful not only for disposing a stent into the myocardium but also for the treatment of aneurysms.
  • Aneurysms are typically treated by introducing embolic elements to fill the aneurysm.
  • FIG. 16 illustrates a method for solving this problem using the delivery catheter 70 described above with respect to FIGS. 15C and 15D.
  • a catheter 70 carrying inflatable balloon 80 is advanced such that the balloon 80 is adjacent the aneurysm 92 .
  • the balloon 80 is inflated to substantially enclose the aneurysm 92 .
  • a wire 94 or other embolic element is advanced through the guide lumen 88 of balloon 80 and out side port 82 .
  • the wire 94 fills up the aneurysm 92 , and is maintained in the aneurysm due to the fact that the balloon 80 encloses the aneurysm to prevent wire 94 from extending into the vessel.
  • the wire 94 or other embolic element may also be delivered through a lumen 74 , as shown with respect to the embodiment in FIG. 15B.
  • the embodiments described above are directed primarily to providing a guidewire 100 into the patient's myocardium. As described in further detail below, this guidewire is used for delivering medical devices into the myocardium. However, it should be appreciated that many of the embodiments described above may also be used in conjunction with other methods for creating a passageway through the myocardium. For instance, a delivery catheter, such as described above, may be used for delivering a surgical drill or other tissue penetrating device ejected from the distal end thereof. This approach would be useful, for instance, in creating a tunnel through the myocardium as described above. Alternatively, a Seldinger wire may be ejected from the distal end of the delivery catheter. Further details are described in the above-referenced U.S. Pat. No. 5,429,144.
  • a puncture device such as guidewire 100 is directed into the myocardium 100 using any of the preferred methods described above.
  • Guidewire 100 preferably has a proximal end 102 (not shown) which remains outside the patient's body, and a distal end 104 which is inserted through a delivery catheter as described above. Where the delivery catheter is provided through the coronary artery, the guidewire is advanced in one embodiment until the distal end 104 of the guidewire enters the left ventricle. Alternatively, where it is desired that a stent or other device extend only partially into the myocardium, the guidewire 100 need not extend all the way through to the left ventricle.
  • the distal tip 104 of the guidewire 100 is preferably made of a radiopaque material that can be visualized by the physician by an available method, such as fluoroscopy.
  • the distal end of the guidewire 100 is preferably formed such that it is easily advanced but is difficult to pull back through the tissue.
  • one embodiment of the distal tip 104 comprises one or more barbs 106 extending from the tip in a type of “multi-winged arrowhead” configuration. These barbs allow the guidewire to be advanced distally into the myocardium but require more force to pull the guidewire 100 proximally out of the myocardium, thus creating an effective anchor.
  • FIG. 18A shows another embodiment wherein a guidewire 100 carries an expandable member such as balloon 110 on its distal end.
  • an expandable member such as balloon 110 on its distal end.
  • Use of an expandable member reduces damage to the myocardium during subsequent retraction of the wire 100 .
  • FIG. 18B once the balloon 110 reaches the left ventricle LV, the balloon 110 is inflated. The balloon is then preferably pulled proximally back to the ventricle wall to anchor and secure the guidewire 100 in place.
  • FIGS. 19 A- 19 C show an expandable guidewire 100 extending through and actuated to anchor the guidewire within the myocardium MYO.
  • a guidewire 100 is shown advanced through the myocardium MYO.
  • Guidewire 100 is provided with an expandable device 112 on distal end 104 which may be actuated by an operator at the proximal end of the guidewire outside of the patient. Actuating of the device may be accomplished by using a shape memory material such as nitinol and heating the material above its transformation temperature. Alternatively, the guidewire may be mechanically actuated to assume the desired shape.
  • FIG. 19A a guidewire 100 is shown advanced through the myocardium MYO.
  • Guidewire 100 is provided with an expandable device 112 on distal end 104 which may be actuated by an operator at the proximal end of the guidewire outside of the patient. Actuating of the device may be accomplished by using a shape memory material such as nitinol and heating the material above its transformation
  • FIG. 19B shows the guidewire 100 partially actuated at its distal end 104 to expand the device 112 into an anchorable shape.
  • FIG. 19C shows the expandable device 112 fully actuated to anchor the guidewire 100 against the ventricle wall.
  • Other types of anchoring and expandable members may also be used to secure the guidewire 100 .
  • the delivery catheter may be removed without displacing the guidewire inserted through the myocardium. Then, with the guidewire 100 anchored in place, catheters used in creating and stenting the passageway or other medical devices may be provided into the myocardium. Alternatively, the delivery catheter may remain within the blood vessel and other catheters or medical devices may be advanced over the guidewire and through the delivery catheter. Furthermore, an expandable member such as a balloon may be provided on the delivery catheter or on the guidewire 100 to anchor the catheter or guidewire to the wall of the blood vessel to provide for more secure deployment of medical devices into the myocardium.
  • an expandable member such as a balloon may be provided on the delivery catheter or on the guidewire 100 to anchor the catheter or guidewire to the wall of the blood vessel to provide for more secure deployment of medical devices into the myocardium.
  • the anchoring of the guidewire 100 within the myocardium MYO allows for the delivery of devices into the myocardium for creation of a myocardial passageway.
  • the anchoring of the guidewire 100 facilitates advancement of over-the-wire catheters such as introducer catheters into the myocardium by employing a push-pull mechanism.
  • the guidewire 100 may be pulled proximally by an operator from outside of the body.
  • the anchoring member at the distal end of the guidewire whether a balloon, barb, or other member, prevents the guidewire 100 from exiting the myocardium MYO.
  • a delivery catheter or other over-the-wire device may be pushed into the myocardium MYO, assisted by the pulling force of the anchoring member toward the catheter.
  • the anchoring member also assists in placement of an over-the-wire catheter in the myocardium by preventing the catheter from extending beyond the location of the anchoring member.
  • a catheter 120 having a dilation balloon 122 is advanced over guidewire 100 , into the myocardium MYO, as shown in FIG. 21.
  • the anchored balloon 110 acts as a barrier to advancement of balloon 122 , which is subsequently inflated within myocardium MYO to expand a myocardial passageway.
  • the balloon 122 is then deflated and the catheter 120 removed. The process may be repeated with successively larger dilation balloons to form a passageway of desired size.
  • the catheter 120 After inflation of the largest desired dilation balloon, the catheter 120 is withdrawn and a stent introducer catheter 130 is advanced over wire 100 , as shown in FIG. 22.
  • the catheter 130 has an inflatable balloon 132 mounted on its distal end for deploying a stent 134 carried by balloon 132 .
  • balloon 132 Upon the positioning of balloon 132 inside the myocardium MYO, balloon 132 is inflated, as shown in FIG. 23, to assist in an initial expansion of stent 134 in opposition to the compressive forces of the heart muscle.
  • balloon 132 Upon the desired disposition of stent 134 , balloon 132 is deflated and catheter 130 and wire 100 are withdrawn, leaving stent 134 in place to provide a coronary bypass between ventricle LV and artery CA.
  • the guidewire such as described above delivered into the myocardium MYO may also be used for delivering drugs into the myocardium.
  • a guidewire 140 is advanced partially into the myocardium using any of the methods described above.
  • the guidewire 140 comprises a tubular body 142 having a lumen 148 (not shown) extending from a proximal end 144 (not shown) to a distal end 146 .
  • the guidewire may be angled using the turning methods described above to provide the distal end of the guidewire at a desired position within the myocardium for drug delivery.
  • Drug delivery fluids 150 are ejected from the distal and 146 into the myocardium.
  • anchoring means as described above may be provided.
  • the guidewire 140 may contain a plurality of ports 152 along the tubular body 142 near the distal end 146 .

Abstract

Described herein are various methods and apparatuses for delivering stents and other devices into the myocardium of a patient. One preferred stent delivery system provides access to the insertion site in the myocardium by advancing a delivery catheter through a blockage in a coronary artery, or around the blockage through a coronary vein or through a channel or tunnel formed around the blockage. In one embodiment, once the distal end of the delivery catheter is adjacent the myocardium, an angled bend is created in the catheter by actuating expandable steering guides mounted to the catheter which cooperate with the walls of the blood vessel to cause the catheter to turn. Then, a guidewire is advanced through the delivery catheter and into the myocardium. In another embodiment, a tip-deflecting pull wire extends from the distal end of the delivery catheter which may be actuated to turn towards and then inserted into the myocardium. In another embodiment, an exit port facing the insertion site is provided within the catheter or a balloon mounted on the catheter so that a guidewire may be directed through a lumen and out the exit port into the myocardium. Once the guidewire punctures into the myocardium, the guidewire is anchored using barbs, balloons or other actuatable members to secure the guidewire to the myocardium. Subsequently, using a push-pull mechanism, stents and other medical devices can be advanced over the guidewire into the myocardium.

Description

    BACKGROUND OF THE INVENTION
  • 1. Field of the Invention [0001]
  • The present invention relates to the delivery of a stent and other devices into the myocardium of a patient, and more particularly, to a stent delivery system to provide a bypass through the myocardium from the left ventricle into a coronary artery. [0002]
  • 2. Description of the Related Art [0003]
  • Coronary arteries as well as other vessels frequently become clogged with plaque that at the very least impairs the efficiency of the heart's pumping action and can lead to heart attack and death. One conventional treatment for clogged coronary or other arteries is a bypass operation wherein one or more venous segments are inserted between the aorta and the coronary artery. The inserted venous segments or transplants act as a bypass of the clogged portion of the coronary artery and thus provide for a free or unobstructed flow of blood to the heart. [0004]
  • Such coronary artery bypass surgery, however, is expensive, time-consuming and traumatic to the patient. Hospital stays subsequent to the surgery and convalescence are prolonged. [0005]
  • A new coronary artery bypass technique is disclosed in U.S. Pat. No. 5,429,144. That technique utilizes a stent made of a biocompatible material and comprises steps of moving the stent in a collapsed configuration through a blood vessel of a patient's vascular system to the patient's heart, inserting the stent in the patient's myocardium, and upon disposition of the stent in the myocardium, expanding the stent from the collapsed configuration to a substantially tubular expanded configuration so that a blood flow path is formed at least partially through the myocardium. [0006]
  • One problem with the coronary artery bypass method providing a stent through the myocardium of the heart is how to get the stent into the myocardium. U.S. Pat. No. 5,429,144 describes a percutaneous approach wherein the stent is brought to the myocardium through the patient's vasculature on the distal end of a catheter, and advanced into the myocardium over a guidewire. One particular challenge is how to make an angled bend in the guidewire to puncture through the wall of the vessel and into the myocardium. [0007]
  • Another problem with this approach is that catheters delivering the guidewire, stent or other devices to be provided into the myocardium are conventionally guided to the puncture point through the blockage in the coronary artery. However, when the blockage is too large, a delivery catheter cannot access the desired insertion site. [0008]
  • In addition, it is often difficult to advance devices into the myocardium because of the traction and force necessary to push through the myocardium. This problem arises not only for delivery of the stent, but also for the delivery of dilation catheters used to expand the cross-section of the passageway through the myocardium, and other devices. [0009]
  • Accordingly, what is needed is a method and apparatus for delivering guidewires, stents and other devices into the myocardium. In particular, what is needed is a delivery system that can deliver these devices at an angled bend for transverse insertion into the myocardium. Moreover, what is needed is a delivery method and apparatus for advancing a delivery catheter to a puncture site in a coronary vessel when the blockage in the vessel is too large to permit passage of a catheter therethrough. What is also needed is a method and apparatus for advancement of a stent, dilation catheter or other device into and through the myocardium. [0010]
  • SUMMARY OF THE INVENTION
  • Briefly stated, the present invention addresses the above needs by providing various methods and apparatuses for delivering stents and other devices into the myocardium of a patient. One preferred stent delivery system provides access to the insertion site in the myocardium by advancing a delivery catheter through a blockage in a coronary artery, or around the blockage through a coronary vein or through a channel or tunnel formed around the blockage. In one embodiment, once the distal end of the delivery catheter is adjacent the myocardium, an angled bend is created in the catheter by actuating expandable steering guides mounted to the catheter which cooperate with the walls of the blood vessel to cause the catheter to turn. Then, a guidewire is advanced through the delivery catheter and into the myocardium. In another embodiment, a tip-deflecting pull wire extends from the distal end of the delivery catheter which may be actuated to turn towards and then inserted into the myocardium. In another embodiment, an exit port facing the insertion site is provided within the catheter or a balloon mounted on the catheter so that a guidewire may be directed through a lumen and out the exit port into the myocardium. Once the guidewire punctures into the myocardium, the guidewire is anchored using barbs, balloons or other actuatable members to secure the guidewire to the myocardium. Subsequently, using a push-pull mechanism, stents and other medical devices can be advanced over the guidewire into the myocardium. [0011]
  • In one aspect of the present invention, a guidewire is delivered into the patient such that the proximal end of the guidewire extends out of the patient, while the distal end of the guidewire is positioned adjacent the myocardium. The distal end of the guidewire is inserted into the myocardium, and the guidewire is then anchored to the myocardium. An introducer catheter carrying a medical device is advanced over the guidewire to deliver the device into the myocardium. [0012]
  • In another aspect of the present invention, a method for delivering a stent into the myocardium to bypass a blockage formed in a coronary artery is provided. A channel is created from a position proximal to the blockage in the coronary artery to a position distal to the blockage in the coronary artery. A guidewire is advanced through the channel until a distal end of the guidewire is adjacent the myocardium. The guidewire is inserted into the myocardium, and a stent is advanced over the guidewire into the myocardium. [0013]
  • In another aspect of the present invention, a method is provided for creating a bypass through the myocardium of a patient to bypass a blockage formed in a coronary artery. A first tunnel is created through the myocardium having a proximal end and a distal end. The proximal end of the tunnel opens into the coronary artery proximal to the blockage. The distal end of the tunnel is positioned within the myocardium. A second tunnel is created through the myocardium, the second tunnel having a first branch extending from the distal end of the first tunnel and opening into the coronary artery at a position distal to the blockage. A second branch of the second tunnel extends from the distal end of the first channel and opens into the left ventricle. A stent is disposed in the second tunnel to provide a myocardial passageway therethrough. [0014]
  • In another aspect of the present invention, a delivery catheter is provided. This delivery catheter comprises an elongate tubular body having a proximal end and a distal end and a lumen extending therethrough. A first steering member is mounted on the distal end of the tubular body, and a second steering member is mounted on the distal end of the tubular body at a position distal to that of the anchoring member. [0015]
  • In another aspect of the present invention, a method for turning a distal end of a catheter within a body lumen is provided. The catheter comprises an elongate tubular body having a proximal end and a distal end. An anchoring member mounted to the distal end is actuated to secure the catheter against the body lumen. A steering member is mounted to the distal end of the of the guidewire at a position distal to that of the anchoring member. When actuated, the steering member cooperates with the body lumen to turn the distal end of the catheter. [0016]
  • In another aspect of the present invention, a method is provided for delivering a medical device to a delivery site within a patient. This method comprises providing a delivery catheter having a proximal end and a distal end and a lumen extending therethrough into a body lumen of the patient. The delivery catheter is secured within the body lumen. The distal end of the catheter is turned by actuating a steering member mounted on the distal end of the catheter which pushes off against a wall of the body lumen. The medical device is advanced through the lumen of the delivery catheter and out the distal end. [0017]
  • In another aspect of the present invention, a method for delivering a stent into the myocardium of a patient is provided. A delivery catheter is advanced into the vasculature of the patient, the delivery catheter having a proximal end and a distal end and a lumen extending therethrough, until the distal end is adjacent the myocardium. A pull wire extending from the distal end of the delivery catheter is actuated to turn the pull wire toward the myocardium. The pull wire is advanced from the distal end of the delivery catheter into the myocardium. The stent is delivered over the pull wire into the myocardium. [0018]
  • In another aspect of the present invention, a method for delivering a stent into the myocardium of a patient is provided. A delivery catheter is advanced into the vasculature of the patient, the catheter having a proximal end and a distal end and a lumen extending from the proximal end to a side port near the distal end, until the side port faces the myocardium. A guidewire having a proximal end and a distal end is inserted into the lumen. The distal end of the guidewire is advanced through the lumen and out the side port. The guidewire punctures into the myocardium, and the stent is delivered over the guidewire into the myocardium. [0019]
  • In another aspect of the present invention, a method for delivering a stent into the myocardium of a patient is provided. A delivery catheter is advanced into the vasculature of a patient, the catheter having a proximal end and a distal end, until the distal end is adjacent the myocardium. An anchoring member mounted on the distal end of the catheter is expanded to secure the delivery catheter within the vasculature. A guidewire having a proximal end and a distal end is inserted through a lumen in the expanded anchoring member, the lumen extending from a proximal end of the anchoring member to a side port facing the myocardium, so that the distal end of the guidewire exits through the side port. The guidewire punctures into the myocardium, and the stent is advanced over the guidewire into the myocardium. [0020]
  • In another aspect of the present invention, a delivery catheter is provided. The catheter comprises an elongate body having a proximal end and a distal end. An expandable member is mounted on the distal end of the tubular body, the expandable member having a proximal end and a distal end and an exterior surface. A guide lumen extends from the proximal end of the balloon to a side port on the exterior surface of the expandable member for directing a medical device therethrough. [0021]
  • In another aspect of the present invention, a method for treating an aneurysm is provided. A catheter having a proximal end and a distal end is advanced to the site of the aneurysm. An expandable member mounted on the distal end of the catheter is actuated to substantially enclose the aneurysm. An embolic element is inserted through a lumen in the expandable member into the aneurysm. [0022]
  • In another aspect of the present invention, a method for delivering a medical device into a body tissue of a patient is provided. The method comprises inserting a guidewire having a proximal end and a distal end into the myocardium from a coronary blood vessel. The guidewire is anchored to the body tissue, and the medical device is pushed over the guidewire into the body tissue. The proximal end of the guidewire is correspondingly pulled proximally while the medical device is pushed distally in order to assist advancing the medical device through the body tissue. [0023]
  • In another aspect of the present invention, a delivery system for directing medical treatment at least partially into the myocardium is provided. The delivery system comprises a guidewire having a proximal end and a distal end, means for turning the distal end of the guidewire toward the myocardium, means for anchoring the guidewire to the myocardium, and a catheter carrying the medical treatment having a lumen extending therethrough for receiving the guidewire and advancing the catheter into the myocardium. [0024]
  • In another aspect of the present invention, a method for delivering a stent into the myocardium of a patient to bypass a blockage formed in a coronary artery is provided. The method comprises advancing a catheter having a proximal end and a distal end and a lumen extending at least partially therethrough from the proximal end to a distal opening through the coronary artery of the patient until the distal opening is past the blockage. The catheter is turned so that the distal opening faces the myocardium. A wire having a proximal end and a distal end is extended through the distal opening such that the distal end punctures into the myocardium. The distal end of the wire is anchored to the myocardium. A dilation catheter is delivered over the wire, the catheter carrying a dilation balloon on a distal end thereof, until the balloon is within the myocardium. The dilation balloon is inflated to create an opening in the myocardium. The dilation balloon is then deflated and the dilation catheter removed from the wire. A stent introducer catheter is delivered over the wire, the stent introducer catheter carrying a stent on a distal end thereof, until the stent is located within the opening in the myocardium. The stent is deployed within the opening in the myocardium. [0025]
  • In another aspect of the present invention, a method for delivering medical treatment into the myocardium of a patient is provided. A tubular wire is delivered into the patient, the wire having a lumen extending therethrough. The wire once delivered has a proximal end extending out of the patient and a distal end positioned adjacent the myocardium. Means for turning the distal end of the wire towards the myocardium are provided. Then, the distal end of the wire is inserted into the myocardium. Medical treatment is delivered through the lumen in the wire into the myocardium.[0026]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a schematic, cross-sectional view of a human heart, showing a stent in the myocardium of the heart for forming a bypass shunt between the left ventricle and a coronary artery. [0027]
  • FIG. 1B is an enlarged view of the bypass shunt of FIG. 1A. [0028]
  • FIG. 2 is a schematic, partial cross-sectional view of a human heart, showing a stent extending partially into the myocardium from the left ventricle. [0029]
  • FIG. 3A is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a delivery catheter being advanced through a blockage in the coronary artery. [0030]
  • FIG. 3B is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a delivery catheter being advanced into the left ventricle. [0031]
  • FIG. 4A is a schematic side view of a venous access route through a patient's heart. [0032]
  • FIG. 4B is a schematic, partial cross-sectional view of the venous access route of FIG. 4A between a coronary vein and a coronary artery, showing a delivery catheter being advanced through the coronary vein into the coronary artery. [0033]
  • FIG. 5 is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a tunnel formed through the myocardium to bypass a blockage in the coronary artery. [0034]
  • FIG. 6 is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a delivery catheter being advanced through a tunnel formed through the myocardium. [0035]
  • FIG. 7 is a schematic, partial cross-sectional view of a coronary artery adjacent the left ventricle, showing a Y-shaped tunnel formed through the myocardium to bypass a blockage in the coronary artery. [0036]
  • FIG. 8 is a partial cross-sectional view of the Y-shaped tunnel of FIG. 7, showing a stent provided therein. [0037]
  • FIG. 9 is a side view of a delivery catheter carrying two uninflated steering balloons in a blocked coronary artery, with the artery shown partially cut away. [0038]
  • FIG. 10 is a side view of the delivery catheter of FIG. 9, showing the two balloons partially inflated. [0039]
  • FIG. 11 is a side view of the delivery catheter of FIG. 9, showing the two balloons fully inflated and a guidewire extending from the distal end of the delivery catheter. [0040]
  • FIG. 12 is a side view of a delivery catheter with a tip deflecting wire in a blocked coronary artery, with the artery shown partially cut away. [0041]
  • FIG. 13A is a side view of a delivery catheter having a side port proximal to an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away. [0042]
  • FIG. 13B is a cross-sectional view of the delivery catheter of FIG. 13A, further showing a guidewire extending therethrough. [0043]
  • FIG. 14A is a side view of a delivery catheter having a side port distal to an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away. [0044]
  • FIG. 14B is a cross-sectional view of the delivery catheter of FIG. 14A, further showing a guidewire extending therethrough. [0045]
  • FIG. 15A is a side view of a delivery catheter having a side port within an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away. [0046]
  • FIG. 15B is a cross-sectional view of the delivery catheter of FIG. 15A, further showing a guidewire extending through the balloon. [0047]
  • FIG. 15C is a side view of an alternative embodiment of a delivery catheter having a side port within an inflatable balloon in a blocked coronary artery, with the artery shown partially cut away. [0048]
  • FIG. 15D is a cross-sectional view of the delivery catheter of FIG. 15C, further showing a guidewire extending through the balloon. [0049]
  • FIG. 16 is a side view of a delivery catheter having a side port within an inflatable balloon used for treating an aneurysm in a blood vessel, with the vessel shown partially cut away. [0050]
  • FIG. 17 is a side view of an anchoring guidewire extending through the myocardium, with the myocardium shown partially cut away. [0051]
  • FIG. 18A is a side view of a guidewire carrying an inflatable balloon on its distal end extending through the myocardium, with the myocardium shown partially cut away. [0052]
  • FIG. 18B is a side view of the guidewire of FIG. 18A, showing the balloon inflated to anchor the guidewire against the myocardium. [0053]
  • FIGS. [0054] 19A-19C are side views of an alternative embodiment of a guidewire anchored to the inner wall of the myocardium, with the myocardium shown partially cut away.
  • FIG. 20 is a side view of a dilation catheter in a coronary artery advanced over a guidewire extending into the myocardium, with the artery and the myocardium shown partially cut away. [0055]
  • FIG. 21 is a side view of the dilation catheter of FIG. 20 advanced into the myocardium. [0056]
  • FIG. 22 is a side view of a stent introducer catheter in a coronary artery advanced over a guidewire extending into the myocardium, with the artery and myocardium shown partially cut away. [0057]
  • FIG. 23 is a side view of the stent introducer catheter of FIG. 22 advanced into the myocardium. [0058]
  • FIG. 24 is a side view of a drug delivery wire advanced through a coronary artery into the myocardium, with the artery and the myocardium shown partially cut away.[0059]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • The preferred embodiments described hereinbelow depict methods and apparatuses for delivering a stent into the myocardium to create a passageway between the left ventricle and coronary artery. It should be appreciated, however, that these embodiments may also be applied to the delivery of stents and other medical devices into other body tissues and vessels, and are particularly applicable for delivering devices at an angled bend relative to the axis of blood flow. In addition, the delivery methods and apparatuses described herein pertain to the placement of stents and other devices partially through the myocardium, as well as for drug delivery and similar applications. [0060]
  • As illustrated in FIGS. 1A and 1B, a coronary artery bypass is accomplished by disposing a [0061] stent 10 in a heart wall or myocardium MYO of a patient's heart PH. Stent 10 preferably extends from the left ventricle LV of heart PH to a clogged coronary artery CA at a point downstream of a blockage BL to create a shunt 12 therethrough. Stent 10 is preferably made of a biocompatible material such as stainless steel or nitinol, although other materials such as Ti, Ti alloys, Ni alloys, Co alloys and biocompatible polymers may also be used. Stent 10 preferably has a one way valve 14 to allow blood to flow from the left ventricle LV to the coronary artery CA. Although the stent 10 may elastically deform under the contractive pressure of the heart muscle during systole, the stent remains open to allow blood to pass from the patient's left ventricle LV into the coronary artery CA. During diastole, the blood pumped into coronary artery through shunt 12 is blocked by one-way valve 14 from returning to left ventricle LV. Further details are disclosed in U.S. Pat. No. 5,429,144, the entirety of which is hereby incorporated by reference. Other types of stents may also be used in accordance with the preferred embodiments described herein.
  • FIG. 2 illustrates another application for which it is desirable to dispose a stent into the myocardium of a patient. In this application, a [0062] stent 10 is provided partially through the myocardium MYO from the left ventricle LV. The stent 10 guides blood directly into the myocardium MYO from the left ventricle to replenish oxygen-deprived heart muscle. Further details are disclosed in the above-referenced U.S. Pat. No. 5,429,144. Other applications providing a stent in the myocardium, extending either partially or entirely therethrough and accessed from either the coronary artery or the left ventricle, are also contemplated by the present invention.
  • To achieve some or all of the objects of the present invention, in particular creating a myocardial passageway between the left ventricle LV and the coronary artery CA for disposition of a stent therein, requires a delivery system capable of directing the necessary devices to and into the myocardium. As described in further detail below, the suitable delivery system: (1) provides access to the insertion site adjacent the myocardium; (2) creates an angled bend for transverse insertion of devices into the myocardium; and (3) directs devices into the myocardium for creation of the myocardial passageway. [0063]
  • I. Access to the Myocardium [0064]
  • The delivery system described herein preferably comprises one or more catheters or guidewires inserted percutaneously into the body, such as through the femoral artery and advanced in the patient's vasculature through the aorta AO, shown in FIG. 1A. It should be appreciated that the percutaneous approach is not essential to achieve many of the objects of the invention, and therefore, an open-chest or other approach may also be used. [0065]
  • As shown in FIG. 3A, an exemplary delivery catheter or [0066] guidewire 20 which has been advanced percutaneously through the femoral artery and through aorta AO is advanced through the blockage BL in the coronary artery CA. The distal tip 22 of the catheter is delivered past the blockage so that it is positioned adjacent to a desired insertion point into the myocardium MYO. FIG. 3B shows an alternative access method wherein the catheter 20 is delivered to a position adjacent the myocardium through the left ventricle LV.
  • FIGS. 4A and 4B depict an alternative access route used when a blockage in the coronary artery is too large for the catheter to be passed therethrough. In this alternate embodiment, a [0067] delivery catheter 20 enters the body through an access point preferably in the femoral vein (not shown). The catheter is advanced up the vein to the vena cava VC and into the right atrium RA, as shown in FIG. 4A. Then, the catheter 20 is directed into the coronary sinus CS, and then to the coronary vein CV which runs adjacent to the coronary artery CA.
  • As shown in FIG. 4B, after the [0068] distal tip 22 of catheter 20 is past the blockage BL in the adjacent coronary vein, the delivery catheter 20 is inserted through the vessel wall VW separating the coronary vein CV from the coronary artery CA. Steering of catheter 20 between coronary vein CV and coronary artery CA may be accomplished using the methods and apparatus for turning catheters discussed in further detail below, or other suitable methods. As described in further detail below, the delivery catheter is turned toward the myocardium MYO either for insertion into the myocardium or for directing a guidewire to puncture therethrough. Access to the insertion point may also be accomplished by steering the delivery catheter through the coronary artery CA to a point proximal to the blockage, directing the catheter into the coronary vein to bypass the blockage, and reinserting the catheter from the coronary vein into the coronary artery past the blockage, as shown in FIG. 4B.
  • An alternative method of accessing the myocardium MYO when the blockage BL is too large to pass a catheter therethrough employs creating a channel around the blockage. As illustrated in FIG. 5, a [0069] tunnel 24 is created from the coronary artery CA into the myocardium MYO at a point proximal to the blockage BL. The tunnel may be created using radiation, lasers, or a surgical drill, or any other suitable methods for creating a tunnel. The tunnel 24 extends underneath the blockage BL and connects with the coronary artery CA at a point distal to the blockage BL. As shown in FIG. 6, a delivery catheter 20 is advanced through the coronary artery CA, into the tunnel 24, and back into the coronary artery CA past the blockage BL. It will be appreciated that other methods for diverting a delivery catheter around a blockage may be used, such as directing the catheter through a shunt into the pericardial space outside the coronary artery.
  • While the [0070] tunnel 24 shown in FIG. 6 is described as providing access to a myocardial insertion point for a coronary bypass, it should also be appreciated that this tunneling technique may be useful for obliteration of the blockage BL. In particular, conventional methods for ablating a blockage only permit access to the blockage from one side. By employing the tunneling method shown in FIG. 6, however, a blockage BL can be treated not only from its proximal end, but also from its distal end simultaneously.
  • In an alternative embodiment, a tunnel is created through the myocardium MYO from a point proximal to a blockage in the coronary artery into the left ventricle. As shown in FIG. 7, where a blockage BL substantially occludes a coronary artery CA, a [0071] first tunnel 26 is formed proximally of the blockage BL extending into the myocardium MYO beneath the blockage BL. The tunnel 26 has a proximal end 28 which opens into the coronary artery CA proximal to the blockage BL, and a distal end 30 within the myocardium MYO beneath the blockage BL. A second tunnel 32 extends from the distal end 30 of the first tunnel, with a first branch 34 opening a channel to the coronary artery CA past the location of the blockage BL. A second branch 36 of the second tunnel 32 extends downward from the distal end 30 and opens into the left ventricle LV. As illustrated in FIG. 7, a substantially Y-shaped passageway is thereby created through the myocardium MYO to bypass the blockage BL.
  • As shown in FIG. 8, after formation of the Y-shaped passageway in the myocardium MYO, one or [0072] more stents 10 are provided in the second tunnel 32 extending between the left ventricle LV and the coronary artery CA. This stent 10 opens the myocardial passageway which provides the bypass past blockage BL. Positioning of stent 10 in the tunnel 32 is preferably accomplished by advancing a guidewire through the first tunnel 26 and into each branch 34 and 36 of the second tunnel 32, and then advancing the stent over the guidewire in the manner described below. After placement of the stent, the tunnel 26 between the coronary artery CA and stent 14 is preferably closed at least at distal end 30, and more preferably, also at proximal end 28. Closure of the tunnel may be accomplished by inserting plugs or other blocking means 38, or by sealing the tunnel with sutures or similar methods. Other suitable closure means include occlusion coils and balloons, adhesives such as cyanoacrylate, and plugs such as sold under the trade name GELFOAM. Alternatively, the tunnel may be closed due to the natural contraction of the openings 28 and 30 over time.
  • II. The Delivery Catheter [0073]
  • Once access to the desired insertion site is achieved, an appropriate delivery system is brought to the site. The preferred embodiments described hereinbelow are directed to a delivery system for inserting stents and other medical devices into the myocardium at an angle relative to the axis of blood flow. It should be appreciated that the angle of insertion may be adjusted between 0 and 180 degrees depending on the desired application. Furthermore, while the delivery systems below describe insertion of devices into the myocardium, these systems also enable angled delivery of medical devices into and through other body lumens and tissues. [0074]
  • A. Dual Balloon Delivery System [0075]
  • In one embodiment, the stent delivery system comprises a catheter which creates an angled bend for insertion of devices into the myocardium MYO. FIG. 9 illustrates a [0076] delivery catheter 40 which has been advanced into the coronary artery CA past the blockage BL. Catheter 40 is an elongate tubular body 42 having a lumen 44 (not shown) extending from a proximal end 46 (not shown) to a distal end 48. The catheter 40 is preferably formed from a flexible biocompatible material such as polymers, stainless steel or nitinol.
  • Mounted adjacent [0077] distal end 48 of catheter 40 are two steering guides, which are preferably expandable members such as inflatable balloon 50 and 52. As illustrated, a steering member, such as balloon 52, is preferably located distally of an anchoring member, such as balloon 50, such that steering balloon 52 is disposed near or at the very distal tip 48 of the catheter 40. Balloons 50 and 52 are each preferably mounted on opposite sides of the catheter tubular body 42, such that anchoring balloon 50 is mounted facing lower wall LW adjacent the myocardium MYO, and steering balloon 52 is mounted facing upper wall UW opposite lower wall LW. Alternatively, the anchoring balloon 50 may be mounted concentrically around the tubular body 42 so that inflation of the balloon expands against both the upper and lower walls. It will be appreciated that other devices, such as filters, posts and other expandable members may be used for the anchoring and/or steering members.
  • As shown in FIG. 9, as the [0078] catheter 40 is advanced into position adjacent the myocardium MYO, the balloons 50 and 52 remain uninflated. As illustrated in FIG. 10, once the distal tip 48 of the catheter 40 is positioned adjacent the desired insertion site into the myocardium MYO, the balloons 50 and 52 are inflated. Inflation causes the balloons 50 and 52 to cooperate with the walls of the blood vessel to turn the distal end of the catheter. More particularly, in an intermediate state, anchoring balloon 50 inflates against the lower wall LW of the coronary artery CA, while steering balloon 40 presses against the upper wall UW.
  • As illustrated in FIG. 11, anchoring [0079] balloon 50 acts to secure the tubular body 42 within the coronary artery CA. Inflation of balloon 50 also preferably causes the catheter 40 to displace in a direction opposite lower wall LW, thereby placing the catheter into a better position for transverse insertion of the distal end 48 into the myocardium MYO. Steering balloon 52 is further inflated, causing the distal tip 48 of the tubular body 32 to turn downward towards lower wall LW and myocardium MYO due to the resistance provided by upper wall UW against the balloon. FIG. 11 also illustrates the effect that the dual balloon inflation may have on the upper and lower walls of the coronary artery CA. When balloons 50 and 52 are fully inflated, forces created on the lower wall LW and upper wall UW, respectively, may cause the walls to shift at least slightly in the direction of balloon inflation. In particular, the lower wall LW may have a tendency to bend upwards distally of the balloon 50 toward the distal end 48 of delivery catheter 40 to assist in angling of the catheter.
  • Due to the turning action of [0080] catheter 40 caused by inflation of balloons 50 and 52, as well as the bending of lower wall LW toward distal end 48, once inflation of the balloons 50 and 52 is complete, the distal tip 48 of catheter 30 is positioned at a substantially transverse angle to the lower wall LW of the coronary artery CA and the myocardium MYO. From this position, the catheter 40 may serve as a guide for the delivery of devices used in creating a myocardial passageway. For example, as shown in FIG. 11 and described in further detail below, a puncture wire or guidewire 100 is advanced through the lumen 44 of tubular body 42, and then ejected out the distal tip 48 of the catheter 40 to puncture the lower wall LW into the myocardium MYO.
  • B. Pull Wire Actuator [0081]
  • FIG. 12 illustrates another embodiment for delivering devices transversely into the myocardium MYO of a patient's heart. A [0082] catheter 54 is shown extending through the coronary artery CA past a blockage BL. Catheter 54 comprises an elongate tubular body 56 with a lumen 58 (not shown) extending therethrough from a proximal end 60 (not shown) to a distal end 62. A tip-deflecting puncture wire or pull wire 64 extends from the distal end 62 of the catheter 54. The wire 64 is actuated at the proximal end (not shown) so that it deflects to form a near 90 degree angle relative to the catheter 54. The distal tip 66 of wire 64 is turned so that it is provided adjacent the myocardium MYO. This shape can be locked and the wire 64 is pushed forward through the coronary artery CA and into the wall of the myocardium MYO. As described in further detail below, with the wire 64 in place medical devices are delivered over the wire into the myocardium.
  • C. Side Port [0083]
  • In another embodiment, a delivery catheter is provided with a side port which allows a puncture wire to exit therethrough. As shown in FIGS. 13A and 14A, [0084] delivery catheter 70 comprises an elongate tubular body 72 having a proximal end 76 (not shown) and a distal end 78 and a lumen 74 (not shown) extending at least partially therethrough. Preferably, mounted on distal end 78 is an expandable or anchoring member such as inflatable balloon 80, which is inflated to maintain the position of the catheter 70 within the artery. The balloon 80 is preferably a perfusion type balloon having a channel 86 to allow blood flow through the artery during the procedure. Alternatively, filters or other devices which allow blood flow through the artery while anchoring the catheter 70 may also be utilized. Perfusion may also be provided through a lumen in the tubular body 72. A distal opening or side port exit 82 is provided through the wall of tubular body 72 near the distal end of the catheter extending from lumen 74. The side port 82 may be located either proximal to the balloon 80, as in FIG. 13A, or distal to the balloon 80, as in FIG. 14A. Catheter 70 is delivered through the vasculature until the side port exit 82 is past the location of the blockage BL. Prior to balloon inflation, the catheter 70 is turned about its longitudinal axis so that the opening 82 faces the myocardium.
  • FIGS. 13B and 14B illustrate the pathway for a [0085] guidewire 100 to pass through the lumen 74 of catheter 70. In FIG. 13B, guidewire 100 extends through the lumen 74 toward the distal end 78 of the catheter. Proximal to balloon 80, the lumen 74 turns downward toward side port exit 82. Thus, before guidewire 100 reaches the proximal end of balloon 80, the guidewire 100 is directed out of the side port 82 toward the lower wall LW of the coronary artery CA. A second lumen 84 is also provided within catheter 70 to direct inflation fluid to balloon 80.
  • FIG. 14B shows substantially the same configuration except that the [0086] lumen 74 extends through the balloon 80 such that the side port exit 82 is located distal to the balloon 80. Guidewire 100 therefore extends through lumen 74 and out side port exit 82 toward the lower wall LW. As with FIG. 13B, a second lumen 84 is provided through tubular body 72 to direct inflation fluid into the balloon 80.
  • In another embodiment, as shown in FIG. 15A, the [0087] side port 82 is located on an exterior surface of the balloon 80. After the catheter 70 is delivered to a location past the blockage BL, balloon 80 is inflated. As shown in the cross-sectional view of FIG. 15B, balloon 80 preferably comprises a perfusion channel 86 extending from the proximal end to the distal end of the balloon 80 to allow blood to flow through the vessel. A lumen 74 is provided through the catheter 70 which extends into balloon 80 and turns downward into side port exit 82. The catheter 70 also has a lumen 84 for inflation of balloon 80. Guidewire 100 is advanced through lumen 74 and out side port exit 82 into the myocardium MYO.
  • FIGS. 15C and 15D illustrate yet another embodiment of a delivery catheter with a side port exit. The [0088] catheter 70 comprises an elongate tubular body 72 having a lumen 74 extending from a proximal end 76 (not shown) to distal end 78. This lumen 74 is in fluid communication with balloon 80 to provide inflation of the balloon. When inflated, balloon 80 has a perfusion lumen 86 which allows blood to perfuse therethrough. The balloon 80 also has a guide lumen 88 extending therethrough which, when inflated, extends from a proximal end of the balloon to the lower wall LW. A guidewire 100 may then be inserted through the guide lumen 88 and out side port exit 82 into the myocardium MYO.
  • The delivery catheters described and shown in FIGS. [0089] 15A-15D are useful not only for disposing a stent into the myocardium but also for the treatment of aneurysms. Aneurysms are typically treated by introducing embolic elements to fill the aneurysm. When the aneurysm opens substantially into the blood vessel, it becomes difficult to retain the embolic elements within the aneurysm while the aneurysm is being filled. FIG. 16 illustrates a method for solving this problem using the delivery catheter 70 described above with respect to FIGS. 15C and 15D. In a blood vessel 90 with an aneurysm 92, a catheter 70 carrying inflatable balloon 80 is advanced such that the balloon 80 is adjacent the aneurysm 92. The balloon 80 is inflated to substantially enclose the aneurysm 92. A wire 94 or other embolic element is advanced through the guide lumen 88 of balloon 80 and out side port 82. The wire 94 fills up the aneurysm 92, and is maintained in the aneurysm due to the fact that the balloon 80 encloses the aneurysm to prevent wire 94 from extending into the vessel. It should be appreciated that the wire 94 or other embolic element may also be delivered through a lumen 74, as shown with respect to the embodiment in FIG. 15B. After the aneurysm 92 is filled with wire 94, the wire 94 is cut, the balloon 80 is deflated, and the catheter 70 is removed from the vessel.
  • III. Anchoring Guidewire [0090]
  • The embodiments described above are directed primarily to providing a [0091] guidewire 100 into the patient's myocardium. As described in further detail below, this guidewire is used for delivering medical devices into the myocardium. However, it should be appreciated that many of the embodiments described above may also be used in conjunction with other methods for creating a passageway through the myocardium. For instance, a delivery catheter, such as described above, may be used for delivering a surgical drill or other tissue penetrating device ejected from the distal end thereof. This approach would be useful, for instance, in creating a tunnel through the myocardium as described above. Alternatively, a Seldinger wire may be ejected from the distal end of the delivery catheter. Further details are described in the above-referenced U.S. Pat. No. 5,429,144.
  • As shown in FIG. 17, a puncture device such as [0092] guidewire 100 is directed into the myocardium 100 using any of the preferred methods described above. Guidewire 100 preferably has a proximal end 102 (not shown) which remains outside the patient's body, and a distal end 104 which is inserted through a delivery catheter as described above. Where the delivery catheter is provided through the coronary artery, the guidewire is advanced in one embodiment until the distal end 104 of the guidewire enters the left ventricle. Alternatively, where it is desired that a stent or other device extend only partially into the myocardium, the guidewire 100 need not extend all the way through to the left ventricle. The distal tip 104 of the guidewire 100 is preferably made of a radiopaque material that can be visualized by the physician by an available method, such as fluoroscopy.
  • The distal end of the [0093] guidewire 100 is preferably formed such that it is easily advanced but is difficult to pull back through the tissue. As shown in FIG. 17, one embodiment of the distal tip 104 comprises one or more barbs 106 extending from the tip in a type of “multi-winged arrowhead” configuration. These barbs allow the guidewire to be advanced distally into the myocardium but require more force to pull the guidewire 100 proximally out of the myocardium, thus creating an effective anchor.
  • FIG. 18A shows another embodiment wherein a [0094] guidewire 100 carries an expandable member such as balloon 110 on its distal end. Use of an expandable member reduces damage to the myocardium during subsequent retraction of the wire 100. As illustrated in FIG. 18B, once the balloon 110 reaches the left ventricle LV, the balloon 110 is inflated. The balloon is then preferably pulled proximally back to the ventricle wall to anchor and secure the guidewire 100 in place.
  • Alternatively, FIGS. [0095] 19A-19C show an expandable guidewire 100 extending through and actuated to anchor the guidewire within the myocardium MYO. In FIG. 19A, a guidewire 100 is shown advanced through the myocardium MYO. Guidewire 100 is provided with an expandable device 112 on distal end 104 which may be actuated by an operator at the proximal end of the guidewire outside of the patient. Actuating of the device may be accomplished by using a shape memory material such as nitinol and heating the material above its transformation temperature. Alternatively, the guidewire may be mechanically actuated to assume the desired shape. FIG. 19B shows the guidewire 100 partially actuated at its distal end 104 to expand the device 112 into an anchorable shape. FIG. 19C shows the expandable device 112 fully actuated to anchor the guidewire 100 against the ventricle wall. Other types of anchoring and expandable members may also be used to secure the guidewire 100.
  • Once the [0096] guidewire 100 is anchored in place, the delivery catheter may be removed without displacing the guidewire inserted through the myocardium. Then, with the guidewire 100 anchored in place, catheters used in creating and stenting the passageway or other medical devices may be provided into the myocardium. Alternatively, the delivery catheter may remain within the blood vessel and other catheters or medical devices may be advanced over the guidewire and through the delivery catheter. Furthermore, an expandable member such as a balloon may be provided on the delivery catheter or on the guidewire 100 to anchor the catheter or guidewire to the wall of the blood vessel to provide for more secure deployment of medical devices into the myocardium.
  • IV. Delivery Over the Guidewire [0097]
  • The anchoring of the [0098] guidewire 100 within the myocardium MYO allows for the delivery of devices into the myocardium for creation of a myocardial passageway. In particular, the anchoring of the guidewire 100 facilitates advancement of over-the-wire catheters such as introducer catheters into the myocardium by employing a push-pull mechanism. When it is desired to push a catheter over the guidewire 100, the guidewire 100 may be pulled proximally by an operator from outside of the body. The anchoring member at the distal end of the guidewire, whether a balloon, barb, or other member, prevents the guidewire 100 from exiting the myocardium MYO. Meanwhile, a delivery catheter or other over-the-wire device may be pushed into the myocardium MYO, assisted by the pulling force of the anchoring member toward the catheter. The anchoring member also assists in placement of an over-the-wire catheter in the myocardium by preventing the catheter from extending beyond the location of the anchoring member.
  • As illustrated in FIG. 20, to create a myocardial passageway, a [0099] catheter 120 having a dilation balloon 122 is advanced over guidewire 100, into the myocardium MYO, as shown in FIG. 21. The anchored balloon 110 acts as a barrier to advancement of balloon 122, which is subsequently inflated within myocardium MYO to expand a myocardial passageway. The balloon 122 is then deflated and the catheter 120 removed. The process may be repeated with successively larger dilation balloons to form a passageway of desired size.
  • After inflation of the largest desired dilation balloon, the [0100] catheter 120 is withdrawn and a stent introducer catheter 130 is advanced over wire 100, as shown in FIG. 22. The catheter 130 has an inflatable balloon 132 mounted on its distal end for deploying a stent 134 carried by balloon 132. Upon the positioning of balloon 132 inside the myocardium MYO, balloon 132 is inflated, as shown in FIG. 23, to assist in an initial expansion of stent 134 in opposition to the compressive forces of the heart muscle. Upon the desired disposition of stent 134, balloon 132 is deflated and catheter 130 and wire 100 are withdrawn, leaving stent 134 in place to provide a coronary bypass between ventricle LV and artery CA.
  • V. Drug Delivery [0101]
  • The guidewire such as described above delivered into the myocardium MYO may also be used for delivering drugs into the myocardium. As shown in FIG. 24, a [0102] guidewire 140 is advanced partially into the myocardium using any of the methods described above. The guidewire 140 comprises a tubular body 142 having a lumen 148 (not shown) extending from a proximal end 144 (not shown) to a distal end 146. The guidewire may be angled using the turning methods described above to provide the distal end of the guidewire at a desired position within the myocardium for drug delivery. Drug delivery fluids 150 are ejected from the distal and 146 into the myocardium. Although the guidewire 140 shown in FIG. 24 is not anchored to the myocardium MYO, anchoring means as described above may be provided. Furthermore, the guidewire 140 may contain a plurality of ports 152 along the tubular body 142 near the distal end 146.
  • The embodiments illustrated and described above are provided merely as examples of certain preferred embodiments of the present invention. Other changes and modifications can be made from the embodiments presented herein by those skilled in the art without departure from the spirit and scope of the invention, as defined by the appended claims. [0103]

Claims (68)

What is claimed is:
1. A method for delivering a medical device into the myocardium of a patient, comprising:
delivering a guidewire into the patient, the guidewire once delivered having a proximal end extending out of the patient and a distal end positioned adjacent the myocardium;
inserting the distal end of the guidewire into the myocardium;
anchoring the guidewire to the myocardium; and
advancing an introducer catheter carrying the medical device over the guidewire to deliver the device into the myocardium.
2. The method of
claim 1
, wherein the guidewire is delivered percutaneously into the patient.
3. The method of
claim 2
, wherein the distal end of the guidewire is advanced through a blockage in a coronary artery.
4. The method of
claim 2
, wherein the distal end of the guidewire is advanced through a coronary vein.
5. The method of
claim 2
, wherein the distal end of the guidewire is advanced into the left ventricle.
6. The method of
claim 1
, further comprising advancing a delivery catheter into the patient prior to delivering the guidewire, the delivery catheter comprising a tubular body having a proximal end and a distal end and a lumen extending at least partially therethrough, until the distal end of the delivery catheter is positioned adjacent the myocardium.
7. The method of
claim 6
, further comprising turning the distal end of the guidewire toward the myocardium prior to inserting the distal end of the guidewire, by:
actuating an anchoring member mounted on the distal end of the delivery catheter to secure the delivery catheter within the patient; and
actuating a steering member mounted on the distal end of the tubular body at a position distal to that of the anchoring member to turn the distal end of the delivery catheter toward the myocardium; and
advancing the guidewire through the lumen in the delivery catheter and out the distal end of the delivery catheter.
8. The method of
claim 1
, wherein the guidewire is a tip-deflecting wire, and further comprising turning the distal end of the guidewire toward the myocardium prior to inserting the distal end of the guidewire by actuating the tip-deflecting wire.
9. The method of
claim 1
, further comprising:
providing a passageway adjacent the myocardium having a proximal opening for receiving the distal end of the guidewire and a side port exit facing the myocardium;
wherein delivering the guidewire comprises advancing the distal end of the guidewire through the passageway toward the myocardium.
10. The method of
claim 9
, wherein the passageway is provided through a lumen in a delivery catheter.
11. The method of
claim 9
, wherein the passageway is provided through an anchoring member mounted to a distal end of a delivery catheter.
12. The method of
claim 1
, wherein anchoring the guidewire to the myocardium comprises providing at least one barb attached to the distal end of the guidewire, the barb having a shape that facilitates advancement of the guidewire distally through the myocardium but prevents retraction of the guidewire proximally.
13. The method of
claim 1
, wherein inserting the distal end of the guidewire into the myocardium comprises advancing the guidewire from a coronary blood vessel until the distal end extends into the left ventricle.
14. The method of
claim 1
, wherein anchoring the guidewire further comprises expanding an anchoring member mounted on the distal end of the guidewire within the left ventricle.
15. The method of
claim 14
, wherein the anchoring member is an inflatable balloon.
16. The method of
claim 1
, wherein advancing the introducer catheter carrying a medical device further comprises:
pulling proximally on the guidewire anchored to the myocardium; and
pushing the introducer catheter over the guidewire into the myocardium.
17. A method for delivering a stent into the myocardium to bypass a blockage formed in a coronary artery, comprising:
creating a channel from a position proximal to the blockage in the coronary artery to a position distal to the blockage in the coronary artery;
advancing a guidewire through the channel until a distal end of the guidewire is adjacent the myocardium;
inserting the guidewire into the myocardium; and
advancing a stent over the guidewire into the myocardium.
18. The method of
claim 17
, wherein the channel is a tunnel formed through the myocardium.
19. A method for creating a bypass through the myocardium of a patient to bypass a blockage formed in a coronary artery, comprising:
creating a first tunnel through the myocardium having a proximal end and a distal end, the proximal end opening into the coronary artery proximal to the blockage, and the distal end positioned within the myocardium;
creating a second tunnel through the myocardium, the second tunnel having a first branch extending from the distal end of the first tunnel and opening into the coronary artery at a position distal to the blockage, and a second branch extending from the distal end of the first channel and opening into the left ventricle; and
disposing a stent in the second tunnel to provide a myocardial passageway therethrough.
20. The method of
claim 19
, further comprising closing off the first tunnel at the distal end thereof.
21. The method of
claim 19
, further comprising closing off the first tunnel at the proximal end thereof.
22. A delivery catheter, comprising:
an elongate tubular body having a proximal end and a distal end and a lumen extending therethrough;
a first steering member mounted on the distal end of the tubular body; and
a second steering member mounted on the distal end of the tubular body at a position distal to that of the anchoring member.
23. The catheter of
claim 22
, wherein the first steering member is an expandable anchoring member which, when actuated, is sized to press against a wall of the body lumen to secure the catheter within the lumen.
24. The catheter of
claim 23
, wherein the second steering member is an expandable member which, when actuated, cooperates with a wall of the body lumen to turn the distal end of the catheter.
25. The catheter of
claim 22
, wherein the anchoring member and steering member are inflatable balloons.
26. The catheter of
claim 22
, wherein the anchoring member is mounted to one side of the tubular body and the steering member is mounted to an opposite side of the tubular body.
27. A method for turning a distal end of a catheter within a body lumen, the catheter comprising an elongate tubular body having a proximal end and a distal end, the method comprising:
actuating an anchoring member mounted on the distal end of the tubular body to secure the catheter against the body lumen; and
actuating a steering member mounted on the distal end of the tubular body at a position distal to that of the anchoring member, wherein the steering member when actuated cooperates with the body lumen to turn the distal end of the catheter.
28. The method of
claim 27
, wherein the anchoring member and the steering member are inflatable balloons.
29. A method for delivering a medical device to a delivery site within a patient comprising:
providing a delivery catheter having a proximal end and a distal end and a lumen extending therethrough into a body lumen of the patient;
securing the delivery catheter within the body lumen;
turning the distal end of the catheter by actuating a steering member mounted on the distal end of the catheter which pushes off against a wall of the body lumen; and
advancing the medical device through the lumen of the delivery catheter and out the distal end.
30. The method of
claim 29
, wherein the steering member when actuated pushes off a wall of the body lumen to turn the distal end of the catheter.
31. The method of
claim 29
, wherein securing the delivery catheter comprises actuating an anchoring member mounted on the distal end of the catheter against the wall of the body lumen.
32. The method of
claim 31
, wherein actuating the anchoring member comprises inflating a balloon against the wall of the body lumen.
33. The method of
claim 29
, wherein actuating the steering member comprises inflating a balloon against the wall of the body lumen.
34. A method for delivering a stent into the myocardium of a patient, comprising:
advancing a delivery catheter into the vasculature of the patient, the delivery catheter having a proximal end and a distal end and a lumen extending therethrough, until the distal end is adjacent the myocardium;
actuating a pull wire extending from the distal end of the delivery catheter to turn the pull wire toward the myocardium;
advancing the pull wire from the distal end of the delivery catheter into the myocardium; and
delivering the stent over the pull wire into the myocardium.
35. A method for delivering a stent into the myocardium of a patient, comprising:
advancing a delivery catheter into the vasculature of the patient, the catheter having a proximal end and a distal end and a lumen extending from the proximal end to a side port near the distal end, until the side port faces the myocardium;
inserting a guidewire having a proximal end and a distal end into the lumen;
advancing the distal end of the guidewire through the lumen and out the side port;
puncturing the guidewire into the myocardium; and
delivering the stent over the guidewire into the myocardium.
36. The method of
claim 35
, further comprising anchoring the delivery catheter within the vasculature.
37. The method of
claim 35
, wherein anchoring of the delivery catheter comprises expanding an anchoring member mounted to the distal end of the delivery catheter.
38. The method of
claim 37
, wherein the anchoring member is an inflatable balloon.
39. The method of
claim 37
, further comprising perfusing blood through at least on channel in the anchoring member.
40. A method for delivering a stent into the myocardium of a patient, comprising:
advancing a delivery catheter into the vasculature of a patient, the catheter having a proximal end and a distal end, until the distal end is adjacent the myocardium;
expanding an anchoring member mounted on the distal end of the catheter to secure the delivery catheter within the vasculature;
inserting a guidewire having a proximal end and a distal end through a lumen in the expanded anchoring member, the lumen extending from a proximal end of the anchoring member to a side port facing the myocardium, so that the distal end of the guidewire exits through the side port;
puncturing the guidewire into the myocardium; and
advancing the stent over the guidewire into the myocardium.
41. The method of
claim 40
, wherein expanding the anchoring member comprises inflating a balloon.
42. The method of
claim 40
, further comprising perfusing blood through at least one channel in the expanded anchoring member.
43. A delivery catheter, comprising:
an elongate body having a proximal end and a distal end;
an expandable member mounted on the distal end of the tubular body, the expandable member having a proximal end and a distal end and an exterior surface; and
a guide lumen extending from the proximal end of the balloon to a side port on the exterior surface of the expandable member for directing a medical device therethrough.
44. The delivery catheter of
claim 43
, wherein the guide lumen extends through the elongate body from the side port to the proximal end of the elongate body.
45. The delivery catheter of
claim 43
, wherein the guide lumen is separate from the elongate body.
46. The delivery catheter of
claim 43
, wherein the guide lumen curves up to about 90 degrees.
47. The delivery catheter of
claim 43
, wherein the expandable member is an inflatable balloon.
48. The delivery catheter of
claim 43
, further comprising a perfusion channel to allow blood to flow therethrough.
49. The delivery catheter of
claim 48
, wherein the perfusion channel extends through the expandable member.
50. A method for treating an aneurysm, comprising:
advancing a catheter having a proximal end and a distal end to the site of the aneurysm;
actuating an expandable member mounted on the distal end of the catheter to substantially enclose the aneurysm; and
inserting an embolic element through a lumen in the expandable member into the aneurysm.
51. The method of
claim 50
, wherein actuating the expandable member comprises inflating a balloon.
52. The method of
claim 50
, further comprising perfusing blood through at least one channel in the expandable member.
53. The method of
claim 50
, wherein the embolic element is a wire.
54. A method for delivering a medical device into a body tissue of a patient comprising:
inserting a guidewire having a proximal end and a distal end into the myocardium from a coronary blood vessel;
anchoring the guidewire to the body tissue;
pushing the medical device over the guidewire into the body tissue; and
pulling on the proximal end of the guidewire while advancing the medical device through the body tissue.
55. The method of
claim 54
, wherein anchoring the guidewire comprises actuating an expandable member.
56. The method of
claim 55
, wherein the expandable member is an inflatable balloon.
57. The method of
claim 54
, further comprising providing at least one barb on the distal end of the guidewire to anchor the guidewire to the myocardium.
58. A delivery system for directing a medical treatment at least partially into the myocardium, comprising:
a guidewire having a proximal end and a distal end;
means for turning the distal end of the guidewire toward the myocardium;
means for anchoring the guidewire to the myocardium; and
a catheter carrying the medical treatment having a lumen extending therethrough for receiving the guidewire and advancing the catheter into the myocardium.
59. A method for delivering a stent into the myocardium of a patient to bypass a blockage formed in a coronary artery, comprising:
advancing a catheter having a proximal end and a distal end and a lumen extending at least partially therethrough from the proximal end to a distal opening through the coronary artery of the patient until the distal opening is past the blockage;
turning the catheter so that the distal opening faces the myocardium;
extending a wire having a proximal end and a distal end through the distal opening such that the distal end punctures into the myocardium;
anchoring the distal end of the wire to the myocardium;
delivering a dilation catheter over the wire, the catheter carrying a dilation balloon on a distal end thereof, until the balloon is within the myocardium;
inflating the dilation balloon to create an opening in the myocardium;
deflating the dilation balloon and removing the dilation catheter from the wire;
delivering a stent introducer catheter over the wire, the stent introducer catheter carrying a stent on a distal end thereof, until the stent is located within the opening in the myocardium, and
deploying the stent within the opening in the myocardium.
60. A method for delivering medical treatment into the myocardium of a patient, comprising:
delivering a tubular wire having a lumen extending therethrough into the patient, the wire once delivered having a proximal end extending out of the patient and a distal end positioned adjacent the myocardium;
providing a means for turning the distal end of the wire towards the myocardium;
inserting the distal end of the wire into the myocardium; and
delivering the medical treatment through the lumen in the wire into the myocardium.
61. The method of
claim 60
, wherein delivering medical treatment through the lumen comprises providing drug fluid into the lumen at the proximal end.
62. The method of
claim 60
, wherein the distal end of the wire further comprises at least one exit port.
63. The method of
claim 60
, wherein the means for turning the distal end comprises delivering the wire through a delivery catheter.
64. The method of
claim 63
, wherein the means for turning the distal end further comprises:
actuating an anchoring member mounted on a distal end of the delivery catheter to secure the delivery catheter within the patient; and
actuating a steering member mounted on the distal end of the tubular body at a position distal to that of the anchoring member to turn the distal end of the delivery catheter toward the myocardium.
65. The method of
claim 60
, wherein the tubular wire is a pull wire, and the means for turning the distal end comprises actuating the pull wire.
66. The method of
claim 60
, wherein the means for turning the distal end comprises:
providing a curved passageway adjacent the myocardium having a proximal opening for receiving the distal end of the tubular wire and a side port exit facing the myocardium; and
delivering the tubular wire through the curved passageway.
67. The method of
claim 66
, wherein the passageway is provided through a lumen in a delivery catheter.
68. The method of
claim 66
, wherein the passageway is provided through an anchoring member mounted to a distal end of a delivery catheter.
US09/891,663 1998-09-10 2001-06-27 Stent delivery system and method of use Abandoned US20010039445A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US09/891,663 US20010039445A1 (en) 1998-09-10 2001-06-27 Stent delivery system and method of use
US10/625,536 US20040186507A1 (en) 1998-09-10 2003-07-24 Stent delivery system and method of use

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/150,181 US6196230B1 (en) 1998-09-10 1998-09-10 Stent delivery system and method of use
US09/710,884 US6409751B1 (en) 1998-09-10 2000-11-14 Stent delivery system and method of use
US09/891,663 US20010039445A1 (en) 1998-09-10 2001-06-27 Stent delivery system and method of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/710,884 Continuation US6409751B1 (en) 1998-09-10 2000-11-14 Stent delivery system and method of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/625,536 Continuation US20040186507A1 (en) 1998-09-10 2003-07-24 Stent delivery system and method of use

Publications (1)

Publication Number Publication Date
US20010039445A1 true US20010039445A1 (en) 2001-11-08

Family

ID=22533422

Family Applications (4)

Application Number Title Priority Date Filing Date
US09/150,181 Expired - Fee Related US6196230B1 (en) 1998-09-10 1998-09-10 Stent delivery system and method of use
US09/710,884 Expired - Fee Related US6409751B1 (en) 1998-09-10 2000-11-14 Stent delivery system and method of use
US09/891,663 Abandoned US20010039445A1 (en) 1998-09-10 2001-06-27 Stent delivery system and method of use
US10/625,536 Abandoned US20040186507A1 (en) 1998-09-10 2003-07-24 Stent delivery system and method of use

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US09/150,181 Expired - Fee Related US6196230B1 (en) 1998-09-10 1998-09-10 Stent delivery system and method of use
US09/710,884 Expired - Fee Related US6409751B1 (en) 1998-09-10 2000-11-14 Stent delivery system and method of use

Family Applications After (1)

Application Number Title Priority Date Filing Date
US10/625,536 Abandoned US20040186507A1 (en) 1998-09-10 2003-07-24 Stent delivery system and method of use

Country Status (1)

Country Link
US (4) US6196230B1 (en)

Cited By (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582444B2 (en) 1999-08-04 2003-06-24 Percardia, Inc. Blood flow conduit delivery system and method of use
US6605113B2 (en) 1999-08-04 2003-08-12 Percardia Inc. Vascular graft bypass
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US6610100B2 (en) 1998-09-10 2003-08-26 Percardia, Inc. Designs for left ventricular conduit
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US6694983B2 (en) 1998-09-10 2004-02-24 Percardia, Inc. Delivery methods for left ventricular conduit
US20050101903A1 (en) * 2001-08-16 2005-05-12 Percardia, Inc. Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US20090264984A1 (en) * 2001-12-20 2009-10-22 Trivascular2, Inc. Advanced endovascular graft
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US20120109279A1 (en) * 2010-11-02 2012-05-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
WO2012054387A3 (en) * 2010-10-18 2012-07-05 Cameron Haery Apparatus and processes for applying substances within mammalian tissue
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8241346B2 (en) 2001-12-20 2012-08-14 Trivascular, Inc. Endovascular graft and method of delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US20140257248A1 (en) * 2013-03-07 2014-09-11 Volcano Corporation Guidewire with centering mechanism
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10245166B2 (en) 2008-02-22 2019-04-02 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US10603196B2 (en) 2009-04-28 2020-03-31 Endologix, Inc. Fenestrated prosthesis
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
CN113262380A (en) * 2021-04-21 2021-08-17 温州医科大学附属第一医院 Catheter guiding device in ERCP (percutaneous transluminal coronary angioplasty) operation
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
WO2023211455A1 (en) * 2022-04-29 2023-11-02 Bard Peripheral Vascular, Inc. Perfusion balloon catheter and related methods

Families Citing this family (142)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662124A (en) * 1996-06-19 1997-09-02 Wilk Patent Development Corp. Coronary artery by-pass method
AU744343B2 (en) * 1997-04-11 2002-02-21 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
US6651670B2 (en) * 1998-02-13 2003-11-25 Ventrica, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
WO1999040868A1 (en) * 1998-02-13 1999-08-19 Ventrica, Inc. Methods and devices providing transmyocardial blood flow to the arterial vascular system of the heart
US7027398B2 (en) * 2001-04-12 2006-04-11 General Instrument Corporation Method and apparatus for monitoring voice conversations from customer premises equipment
US20020144696A1 (en) * 1998-02-13 2002-10-10 A. Adam Sharkawy Conduits for use in placing a target vessel in fluid communication with a source of blood
EP1112043B1 (en) * 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
WO2000015147A1 (en) * 1998-09-10 2000-03-23 Percardia, Inc. Transmycardial shunt and its attachment mechanism, for left ventricular revascularization
US6196230B1 (en) * 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US7578828B2 (en) * 1999-01-15 2009-08-25 Medtronic, Inc. Methods and devices for placing a conduit in fluid communication with a target vessel
US6409697B2 (en) 1999-05-04 2002-06-25 Heartstent Corporation Transmyocardial implant with forward flow bias
GB2352401B (en) * 1999-07-20 2001-06-06 Ajoy Inder Singh Atheroma ablation
US20060216313A1 (en) * 1999-08-10 2006-09-28 Allergan, Inc. Methods for treating a stricture with a botulinum toxin
US6767544B2 (en) * 2002-04-01 2004-07-27 Allergan, Inc. Methods for treating cardiovascular diseases with botulinum toxin
US6635214B2 (en) * 1999-09-10 2003-10-21 Ventrica, Inc. Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US20080018016A1 (en) * 1999-09-10 2008-01-24 Rapacki Alan R Manufacturing conduits for use in placing a target vessel in fluid communication with a source of blood
US6926689B2 (en) * 2002-03-13 2005-08-09 Albertus Scheule Aortic balloon occlusion cannula
US20060089588A1 (en) * 1999-09-13 2006-04-27 Albertus Scheule Aortic balloon occlusion cannula
AU3885801A (en) * 1999-09-20 2001-04-24 Stereotaxis, Inc. Magnetically guided myocardial treatment system
US6854467B2 (en) * 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US6773446B1 (en) 2000-08-02 2004-08-10 Cordis Corporation Delivery apparatus for a self-expanding stent
US20020016597A1 (en) * 2000-08-02 2002-02-07 Dwyer Clifford J. Delivery apparatus for a self-expanding stent
US6976990B2 (en) * 2001-01-25 2005-12-20 Percardia, Inc. Intravascular ventriculocoronary bypass via a septal passageway
US20030045859A1 (en) * 2001-06-11 2003-03-06 Larry Dominguez Delivery system using balloon catheter
US6814751B2 (en) 2001-10-12 2004-11-09 Rosengart Todd K Method and apparatus for performing an anastamosis
US7066953B2 (en) * 2001-10-12 2006-06-27 Rosengart Todd K Method and apparatus for performing an anastamosis
US20060292206A1 (en) * 2001-11-26 2006-12-28 Kim Steven W Devices and methods for treatment of vascular aneurysms
US6949118B2 (en) * 2002-01-16 2005-09-27 Percardia, Inc. Encased implant and methods
US7008397B2 (en) * 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods
US20030220661A1 (en) * 2002-05-21 2003-11-27 Heartstent Corporation Transmyocardial implant delivery system
US7115134B2 (en) 2002-07-22 2006-10-03 Chambers Technology, Llc. Catheter with flexible tip and shape retention
US7326219B2 (en) * 2002-09-09 2008-02-05 Wilk Patent Development Device for placing transmyocardial implant
WO2004026183A2 (en) 2002-09-20 2004-04-01 Nellix, Inc. Stent-graft with positioning anchor
US8229572B2 (en) * 2008-06-27 2012-07-24 Medtronic, Inc. Lead delivery device and method
US8920432B2 (en) 2002-09-24 2014-12-30 Medtronic, Inc. Lead delivery device and method
US9849279B2 (en) * 2008-06-27 2017-12-26 Medtronic, Inc. Lead delivery device and method
US9480839B2 (en) * 2002-09-24 2016-11-01 Medtronic, Inc. Lead delivery device and method
US9636499B2 (en) * 2002-09-24 2017-05-02 Medtronic, Inc. Lead delivery device and method
US7481821B2 (en) * 2002-11-12 2009-01-27 Thomas J. Fogarty Embolization device and a method of using the same
AU2003272951A1 (en) * 2002-11-19 2004-06-15 Nihon University Balloon catheter and device for injecting medical treatment method
US20040147868A1 (en) * 2003-01-27 2004-07-29 Earl Bardsley Myocardial implant with collar
US20040260382A1 (en) 2003-02-12 2004-12-23 Fogarty Thomas J. Intravascular implants and methods of using the same
IES20030531A2 (en) * 2003-07-17 2005-09-21 Medtronic Vascular Connaught Methods and devices for placing a fistula device in fluid communication with a target vessel
US20050015110A1 (en) * 2003-07-18 2005-01-20 Fogarty Thomas J. Embolization device and a method of using the same
IES20030539A2 (en) 2003-07-22 2005-05-18 Medtronic Vascular Connaught Stents and stent delivery system
US7316709B2 (en) * 2004-01-13 2008-01-08 Advanced Cardiovascular Systems, Inc. Balloon catheter having a textured member for enhancing balloon or stent retention
WO2006012567A2 (en) 2004-07-22 2006-02-02 Nellix, Inc. Methods and systems for endovascular aneurysm treatment
US8048145B2 (en) 2004-07-22 2011-11-01 Endologix, Inc. Graft systems having filling structures supported by scaffolds and methods for their use
US20060030871A1 (en) * 2004-08-05 2006-02-09 Matthew Hain Vascular tunneler
WO2006101718A1 (en) * 2005-03-23 2006-09-28 Wilk Patent, Llc Device and instrument kit for use in trans-vascular surgical method
US20060222596A1 (en) 2005-04-01 2006-10-05 Trivascular, Inc. Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
US20060271154A1 (en) * 2005-05-25 2006-11-30 Prescient Medical, Inc. Methods and systems for treating vulnerable plaque
US20070010781A1 (en) * 2005-06-27 2007-01-11 Venkataramana Vijay Implantable aorto-coronary sinus shunt for myocardial revascularization
EP1898811B1 (en) * 2005-06-30 2019-03-06 Rox Medical, Inc. Devices and systems for creation of a peripherally located fistula
JP2009500121A (en) 2005-07-07 2009-01-08 ネリックス・インコーポレーテッド System and method for treatment of an intraluminal aneurysm
US9149378B2 (en) 2005-08-02 2015-10-06 Reva Medical, Inc. Axially nested slide and lock expandable device
US7914574B2 (en) 2005-08-02 2011-03-29 Reva Medical, Inc. Axially nested slide and lock expandable device
US20070043381A1 (en) * 2005-08-19 2007-02-22 Icon Medical Corp. Medical device deployment instrument
US20070150041A1 (en) * 2005-12-22 2007-06-28 Nellix, Inc. Methods and systems for aneurysm treatment using filling structures
US20070213813A1 (en) * 2005-12-22 2007-09-13 Symetis Sa Stent-valves for valve replacement and associated methods and systems for surgery
US20070203572A1 (en) * 2006-01-25 2007-08-30 Heuser Richard R Catheter system with stent apparatus for connecting adjacent blood vessels
US20070255303A1 (en) * 2006-05-01 2007-11-01 Ethicon Endo-Surgery, Inc. Integrated Guidewire Needle Knife Device
US7790273B2 (en) * 2006-05-24 2010-09-07 Nellix, Inc. Material for creating multi-layered films and methods for making the same
US7872068B2 (en) * 2006-05-30 2011-01-18 Incept Llc Materials formable in situ within a medical device
US7568753B2 (en) * 2006-06-15 2009-08-04 Mattel, Inc. Children's ride-on vehicles with reconfigured bodies and methods for forming the same
EP3078336B1 (en) 2006-11-21 2019-09-18 Bridgepoint Medical, Inc. Endovascular devices for exploiting intramural space
US7941213B2 (en) * 2006-12-28 2011-05-10 Medtronic, Inc. System and method to evaluate electrode position and spacing
US7704275B2 (en) 2007-01-26 2010-04-27 Reva Medical, Inc. Circumferentially nested expandable device
WO2008118737A1 (en) 2007-03-22 2008-10-02 University Of Virginia Patent Foundation Electrode catheter for ablation purposes and related method thereof
WO2008112870A2 (en) 2007-03-13 2008-09-18 University Of Virginia Patent Foundation Epicardial ablation catheter and method of use
WO2011103456A2 (en) 2010-02-18 2011-08-25 University Of Virginia Patent Foundation System, method, and computer program product for simulating epicardial electrophysiology procedures
US9468396B2 (en) 2007-03-19 2016-10-18 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
CA2680639C (en) 2007-03-19 2017-03-07 University Of Virginia Patent Foundation Access needle pressure sensor device and method of use
US11058354B2 (en) 2007-03-19 2021-07-13 University Of Virginia Patent Foundation Access needle with direct visualization and related methods
EP2136706A1 (en) 2007-04-18 2009-12-30 Medtronic, Inc. Chronically-implantable active fixation medical electrical leads and related methods for non-fluoroscopic implantation
ES2586121T3 (en) 2007-08-21 2016-10-11 Symetis Sa Replacement valve
BRPI0819217B8 (en) 2007-10-25 2021-06-22 Symetis Sa replacement valve for use within a human body, system for replacing a valve within a human body, and heart valve release system with stent
WO2009064353A1 (en) * 2007-11-13 2009-05-22 Cook Incorporated Intraluminal bypass prosthesis
JP5216098B2 (en) 2007-11-30 2013-06-19 レヴァ メディカル、 インコーポレイテッド Axial and radially nested expandable device
US7862538B2 (en) * 2008-02-04 2011-01-04 Incept Llc Surgical delivery system for medical sealant
JP2011511701A (en) * 2008-02-13 2011-04-14 ネリックス・インコーポレーテッド Graft inner frame with axially variable properties
US9421065B2 (en) 2008-04-02 2016-08-23 The Spectranetics Corporation Liquid light-guide catheter with optically diverging tip
US8979828B2 (en) 2008-07-21 2015-03-17 The Spectranetics Corporation Tapered liquid light guide
US8494608B2 (en) * 2008-04-18 2013-07-23 Medtronic, Inc. Method and apparatus for mapping a structure
US8340751B2 (en) * 2008-04-18 2012-12-25 Medtronic, Inc. Method and apparatus for determining tracking a virtual point defined relative to a tracked member
US8532734B2 (en) * 2008-04-18 2013-09-10 Regents Of The University Of Minnesota Method and apparatus for mapping a structure
US8663120B2 (en) * 2008-04-18 2014-03-04 Regents Of The University Of Minnesota Method and apparatus for mapping a structure
US8839798B2 (en) * 2008-04-18 2014-09-23 Medtronic, Inc. System and method for determining sheath location
US8260395B2 (en) * 2008-04-18 2012-09-04 Medtronic, Inc. Method and apparatus for mapping a structure
AU2009240419A1 (en) 2008-04-25 2009-10-29 Nellix, Inc. Stent graft delivery system
US20100292530A1 (en) * 2009-05-16 2010-11-18 Uromedica, Inc. Method and apparatus for fixation of implantable devices adjacent a body lumen
US20090319029A1 (en) * 2008-06-04 2009-12-24 Nellix, Inc. Docking apparatus and methods of use
JP2011522615A (en) 2008-06-04 2011-08-04 ネリックス・インコーポレーテッド Sealing device and method of use
US9775989B2 (en) * 2008-06-27 2017-10-03 Medtronic, Inc. Lead delivery device and method
US9775990B2 (en) * 2008-06-27 2017-10-03 Medtronic, Inc. Lead delivery device and method
US20110224655A1 (en) * 2008-09-11 2011-09-15 Asirvatham Samuel J Central core multifunctional cardiac devices
EP2331014B1 (en) 2008-10-10 2017-08-09 Reva Medical, Inc. Expandable slide and lock stent
US8175681B2 (en) 2008-12-16 2012-05-08 Medtronic Navigation Inc. Combination of electromagnetic and electropotential localization
GB2469073A (en) 2009-03-31 2010-10-06 Barking Havering And Redbridge Balloon Assisted Occlusion of Aneurysms
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US8494614B2 (en) 2009-08-31 2013-07-23 Regents Of The University Of Minnesota Combination localization system
US8494613B2 (en) 2009-08-31 2013-07-23 Medtronic, Inc. Combination localization system
US9642534B2 (en) 2009-09-11 2017-05-09 University Of Virginia Patent Foundation Systems and methods for determining location of an access needle in a subject
US8372055B2 (en) * 2009-10-27 2013-02-12 Medtronic, Inc. Method of using a deflectable subselecting catheter
US8355774B2 (en) * 2009-10-30 2013-01-15 Medtronic, Inc. System and method to evaluate electrode position and spacing
CA2778944C (en) 2009-11-02 2019-08-20 Symetis Sa Aortic bioprosthesis and systems for delivery thereof
US20110276078A1 (en) 2009-12-30 2011-11-10 Nellix, Inc. Filling structure for a graft system and methods of use
WO2011127452A1 (en) 2010-04-10 2011-10-13 Reva Medical, Inc Expandable slide and lock stent
CN102309809B (en) * 2010-07-09 2013-11-20 同济大学 Neostomy system
KR101185170B1 (en) * 2010-07-23 2012-09-24 (재)예수병원유지재단 Tunnel type balloon
US20120053485A1 (en) * 2010-09-01 2012-03-01 Salient Surgical Technologies, Inc. Catheter Having Needle And Expandable Support Member And Methods Of Use
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US20130226285A1 (en) * 2010-11-12 2013-08-29 Gera Strommer Percutaneous heart bypass graft surgery apparatus and method
WO2012068298A1 (en) 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US8801768B2 (en) 2011-01-21 2014-08-12 Endologix, Inc. Graft systems having semi-permeable filling structures and methods for their use
EP2676638B1 (en) 2011-02-18 2017-07-12 Piolax Medical Devices, Inc. Stent for abdominal cavity-vein shunt
EP2693980B1 (en) 2011-04-06 2022-07-13 Endologix LLC System for endovascular aneurysm treatment
US9162038B2 (en) 2011-04-11 2015-10-20 The Spectranetics Corporation Needle and guidewire holder
US9814862B2 (en) 2011-06-30 2017-11-14 The Spectranetics Corporation Reentry catheter and method thereof
US8956376B2 (en) * 2011-06-30 2015-02-17 The Spectranetics Corporation Reentry catheter and method thereof
US8998936B2 (en) 2011-06-30 2015-04-07 The Spectranetics Corporation Reentry catheter and method thereof
AU2012347644B2 (en) * 2011-12-09 2017-04-20 Boston Scientific Scimed, Inc. Subintimal recanalization with bio-absorbable stent
US11207176B2 (en) 2012-03-22 2021-12-28 Boston Scientific Scimed, Inc. Transcatheter stent-valves and methods, systems and devices for addressing para-valve leakage
US20130274873A1 (en) 2012-03-22 2013-10-17 Symetis Sa Transcatheter Stent-Valves and Methods, Systems and Devices for Addressing Para-Valve Leakage
JP6533776B2 (en) 2013-03-14 2019-06-19 エンドーロジックス インコーポレイテッド System for treating an aneurysm in a patient's body and method of operating the same
US9446222B2 (en) 2014-03-05 2016-09-20 Invatec S.P.A. Catheter assemblies and methods for stabilizing a catheter assembly within a subintimal space
GB2527075A (en) 2014-03-17 2015-12-16 Daassist As Percutaneous system, devices and methods
US10456557B2 (en) 2014-08-14 2019-10-29 Invatec S.P.A. Occlusion bypassing apparatus with varying flexibility and methods for bypassing an occlusion in a blood vessel
US10172632B2 (en) * 2015-09-22 2019-01-08 Medtronic Vascular, Inc. Occlusion bypassing apparatus with a re-entry needle and a stabilization tube
US10327791B2 (en) 2015-10-07 2019-06-25 Medtronic Vascular, Inc. Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon
US9789294B2 (en) 2015-10-07 2017-10-17 Edwards Lifesciences Corporation Expandable cardiac shunt
US10893847B2 (en) 2015-12-30 2021-01-19 Nuheart As Transcatheter insertion system
WO2017183014A1 (en) * 2016-04-18 2017-10-26 Capsos Medical Limited A branched balloon catheter
US10537672B2 (en) 2016-10-07 2020-01-21 Nuheart As Transcatheter device and system for the delivery of intracorporeal devices
US10335528B2 (en) 2016-10-07 2019-07-02 Nuheart As Transcatheter method and system for the delivery of intracorporeal devices
EP3528885B1 (en) 2016-10-18 2024-03-13 Boston Scientific Scimed Inc. Guide extension catheter
US10537670B2 (en) 2017-04-28 2020-01-21 Nuheart As Ventricular assist device and method
US10888646B2 (en) 2017-04-28 2021-01-12 Nuheart As Ventricular assist device and method
US10350395B2 (en) * 2017-06-23 2019-07-16 Cook Medical Technologies Llc Introducer for lumen support or dilation
US10980653B2 (en) * 2018-10-31 2021-04-20 Anchor Balloon, Llc System and method for controlled delivery of medical devices into patient bodies
WO2023211456A1 (en) * 2022-04-29 2023-11-02 Bard Peripheral Vascular, Inc. Perfusion balloon catheter and related methods

Family Cites Families (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3042021A (en) 1958-11-25 1962-07-03 Read Thane Bypass type insert plug for body passageway
US3419010A (en) 1966-01-17 1968-12-31 Cordis Corp Catheter
US3882862A (en) 1974-01-11 1975-05-13 Olga Berend Arteriovenous shunt
US3911502A (en) 1974-08-23 1975-10-14 Us Health Composite heart valve poppet
US4531936A (en) 1981-01-29 1985-07-30 Gordon Robert T Device and method for the selective delivery of drugs to the myocardium
DE3214397C2 (en) 1982-04-20 1984-07-26 Karl Dr. 6301 Pohlheim Aigner Double lumen perfusion catheter
US4474569A (en) 1982-06-28 1984-10-02 Denver Surgical Developments, Inc. Antenatal shunt
IT1180531B (en) 1984-09-21 1987-09-23 Ge Sv In Srl BICUSPID HEART VALVE PROSTHESIS
US4790810A (en) 1985-11-04 1988-12-13 American Medical Systems, Inc. Ureteral connector stent
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4861330A (en) 1987-03-12 1989-08-29 Gene Voss Cardiac assist device and method
US4836204A (en) 1987-07-06 1989-06-06 Landymore Roderick W Method for effecting closure of a perforation in the septum of the heart
FR2626476B1 (en) 1988-02-01 1997-10-17 Boussignac Georges PROBE FOR INTRODUCTION INSIDE A LIVING BODY
US4979955A (en) 1988-06-06 1990-12-25 Smith Robert M Power assisted prosthetic heart valve
US4955856A (en) 1989-06-30 1990-09-11 Phillips Steven J Method and apparatus for installing a ventricular assist device cannulae
US4973301A (en) 1989-07-11 1990-11-27 Israel Nissenkorn Catheter and method of using same
US5052998A (en) 1990-04-04 1991-10-01 Zimmon David S Indwelling stent and method of use
US5344426A (en) 1990-04-25 1994-09-06 Advanced Cardiovascular Systems, Inc. Method and system for stent delivery
DK124690D0 (en) * 1990-05-18 1990-05-18 Henning Rud Andersen FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION
IT9084979A1 (en) 1990-07-30 1992-01-31 Imad Sheiban PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTIC CATHETER WITH TWO BALLOONS AT ITS DISTAL END ONE OF SMALL DIAMETER (1, 5MM. FOLLOWED BY ANOTHER BALLOON OF GREATER DIAMETER VARIABLE FROM 2, 5 TO 4 MM THE BALLOON THE SMALL BALLOON
US5389096A (en) * 1990-12-18 1995-02-14 Advanced Cardiovascular Systems System and method for percutaneous myocardial revascularization
US5807388A (en) 1994-05-25 1998-09-15 The Trustees Of Columbia University In The City Of New York Myocardial revascularization through the endocardial surface using a laser
US5193546A (en) * 1991-05-15 1993-03-16 Alexander Shaknovich Coronary intravascular ultrasound imaging method and apparatus
US5183464A (en) 1991-05-17 1993-02-02 Interventional Thermodynamics, Inc. Radially expandable dilator
US5190058A (en) 1991-05-22 1993-03-02 Medtronic, Inc. Method of using a temporary stent catheter
US5304220A (en) 1991-07-03 1994-04-19 Maginot Thomas J Method and apparatus for implanting a graft prosthesis in the body of a patient
CA2074304C (en) 1991-08-02 1996-11-26 Cyril J. Schweich, Jr. Drug delivery catheter
US5176626A (en) 1992-01-15 1993-01-05 Wilson-Cook Medical, Inc. Indwelling stent
CA2087132A1 (en) 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
WO1993015791A1 (en) 1992-02-12 1993-08-19 Dimed, Incorporated System for access to pericardial space
US5327913A (en) 1992-03-25 1994-07-12 Taheri Syde A Percutaneus cardiomyoplasty method
US5470320A (en) 1992-04-10 1995-11-28 Tiefenbrun; Jonathan Method and related device for obtaining access to a hollow organ
US5758663A (en) 1992-04-10 1998-06-02 Wilk; Peter J. Coronary artery by-pass method
WO1994002077A2 (en) 1992-07-15 1994-02-03 Angelase, Inc. Ablation catheter system
US5330486A (en) 1992-07-29 1994-07-19 Wilk Peter J Laparoscopic or endoscopic anastomosis technique and associated instruments
US5258008A (en) 1992-07-29 1993-11-02 Wilk Peter J Surgical stapling device and associated method
US5287861A (en) * 1992-10-30 1994-02-22 Wilk Peter J Coronary artery by-pass method and associated catheter
US5409019A (en) 1992-10-30 1995-04-25 Wilk; Peter J. Coronary artery by-pass method
US5429144A (en) * 1992-10-30 1995-07-04 Wilk; Peter J. Coronary artery by-pass method
CA2154784A1 (en) 1993-01-27 1994-08-04 Mordechay Beyar Vascular and coronary stents
US5797960A (en) * 1993-02-22 1998-08-25 Stevens; John H. Method and apparatus for thoracoscopic intracardiac procedures
US5441515A (en) * 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5462544A (en) 1993-05-05 1995-10-31 Energy Life System Corporation Continuous heart tissue mapping and lasing catheter
US5386818A (en) 1993-05-10 1995-02-07 Schneebaum; Cary W. Laparoscopic and endoscopic instrument guiding method and apparatus
US5722972A (en) 1993-08-12 1998-03-03 Power; John A. Method and apparatus for ablation of atherosclerotic blockage
US5431168A (en) 1993-08-23 1995-07-11 Cordis-Webster, Inc. Steerable open-lumen catheter
US5713950A (en) 1993-11-01 1998-02-03 Cox; James L. Method of replacing heart valves using flexible tubes
US5487760A (en) 1994-03-08 1996-01-30 Ats Medical, Inc. Heart valve prosthesis incorporating electronic sensing, monitoring and/or pacing circuitry
US6001123A (en) 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
US5456694A (en) 1994-05-13 1995-10-10 Stentco, Inc. Device for delivering and deploying intraluminal devices
JP3346041B2 (en) 1994-07-20 2002-11-18 アイシン精機株式会社 Anti-skid control device
US5591197A (en) 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
US5571168A (en) 1995-04-05 1996-11-05 Scimed Lifesystems Inc Pull back stent delivery system
US5643278A (en) 1995-04-06 1997-07-01 Leocor, Inc. Stent delivery system
DE19514638C2 (en) * 1995-04-20 1998-06-04 Peter Dr Med Boekstegers Device for the selective suction and retroinfusion of a fluid from or into body veins controlled by venous pressure
US6132451A (en) 1995-06-07 2000-10-17 Eclipse Surgical Technologies, Inc. Optical fiber for myocardial channel formation
US6156031A (en) 1995-08-09 2000-12-05 Eclipse Surgical Technologies Transmyocardial revascularization using radiofrequency energy
DE69633411T2 (en) 1995-10-13 2005-10-20 Transvascular, Inc., Menlo Park METHOD AND DEVICE FOR PREVENTING ARTERIAL ATTRACTIONS AND / OR FOR CARRYING OUT OTHER TRANSVASCULAR INTERVENTIONS
EP0955933B1 (en) 1995-10-13 2009-08-26 Medtronic Vascular, Inc. A device for interstitial transvascular intervention
US6302875B1 (en) 1996-10-11 2001-10-16 Transvascular, Inc. Catheters and related devices for forming passageways between blood vessels or other anatomical structures
US6283983B1 (en) * 1995-10-13 2001-09-04 Transvascular, Inc. Percutaneous in-situ coronary bypass method and apparatus
US6283951B1 (en) 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6726677B1 (en) * 1995-10-13 2004-04-27 Transvascular, Inc. Stabilized tissue penetrating catheters
US6375615B1 (en) * 1995-10-13 2002-04-23 Transvascular, Inc. Tissue penetrating catheters having integral imaging transducers and their methods of use
US5683447A (en) 1995-12-19 1997-11-04 Ventritex, Inc. Lead with septal defibrillation and pacing electrodes
US5865723A (en) 1995-12-29 1999-02-02 Ramus Medical Technologies Method and apparatus for forming vascular prostheses
JP3882015B2 (en) 1996-01-19 2007-02-14 ボストン サイエンティフィック サイムド, インコーポレイテッド Increased radius curve catheter
US6709444B1 (en) * 1996-02-02 2004-03-23 Transvascular, Inc. Methods for bypassing total or near-total obstructions in arteries or other anatomical conduits
US6638293B1 (en) 1996-02-02 2003-10-28 Transvascular, Inc. Methods and apparatus for blocking flow through blood vessels
AU733341B2 (en) * 1996-02-02 2001-05-10 Transvascular, Inc. A device, system and method for interstitial transvascular intervention
WO1997027898A1 (en) 1996-02-02 1997-08-07 Transvascular, Inc. Methods and apparatus for connecting openings formed in adjacent blood vessels or other anatomical structures
US5885258A (en) 1996-02-23 1999-03-23 Memory Medical Systems, Inc. Medical instrument with slotted memory metal tube
US5810836A (en) 1996-03-04 1998-09-22 Myocardial Stents, Inc. Device and method for trans myocardial revascularization (TMR)
AU2821597A (en) 1996-05-03 1997-11-26 Emed Corporation Combined coronary stent deployment and local delivery of an agent
US5676670A (en) 1996-06-14 1997-10-14 Beth Israel Deaconess Medical Center Catheter apparatus and method for creating a vascular bypass in-vivo
US5797920A (en) 1996-06-14 1998-08-25 Beth Israel Deaconess Medical Center Catheter apparatus and method using a shape-memory alloy cuff for creating a bypass graft in-vivo
US5662124A (en) 1996-06-19 1997-09-02 Wilk Patent Development Corp. Coronary artery by-pass method
US5741326A (en) * 1996-07-15 1998-04-21 Cordis Corporation Low profile thermally set wrapped cover for a percutaneously deployed stent
DE69722720T2 (en) 1996-07-24 2004-05-13 Cordis Corp., Miami Lakes Balloon catheter and method of use
US6080170A (en) * 1996-07-26 2000-06-27 Kensey Nash Corporation System and method of use for revascularizing stenotic bypass grafts and other occluded blood vessels
US5755682A (en) 1996-08-13 1998-05-26 Heartstent Corporation Method and apparatus for performing coronary artery bypass surgery
US6007543A (en) 1996-08-23 1999-12-28 Scimed Life Systems, Inc. Stent delivery system with stent securement means
US5980530A (en) 1996-08-23 1999-11-09 Scimed Life Systems Inc Stent delivery system
CA2263672A1 (en) 1996-08-26 1998-03-05 Transvascular, Inc. Methods and apparatus for transmyocardial direct coronary revascularization
US5655548A (en) 1996-09-16 1997-08-12 Circulation, Inc. Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US6186972B1 (en) * 1996-09-16 2001-02-13 James A. Nelson Methods and apparatus for treating ischemic heart disease by providing transvenous myocardial perfusion
US5800450A (en) 1996-10-03 1998-09-01 Interventional Technologies Inc. Neovascularization catheter
US6117153A (en) 1996-10-03 2000-09-12 Interventional Technologies, Inc. Neovascularization catheter
US6379319B1 (en) * 1996-10-11 2002-04-30 Transvascular, Inc. Systems and methods for directing and snaring guidewires
US20020029079A1 (en) * 1996-10-11 2002-03-07 Transvascular, Inc. Devices for forming and/or maintaining connections between adjacent anatomical conduits
US5971993A (en) 1996-11-07 1999-10-26 Myocardial Stents, Inc. System for delivery of a trans myocardial device to a heart wall
US5976178A (en) 1996-11-07 1999-11-02 Vascular Science Inc. Medical grafting methods
US6053924A (en) 1996-11-07 2000-04-25 Hussein; Hany Device and method for trans myocardial revascularization
US6258119B1 (en) 1996-11-07 2001-07-10 Myocardial Stents, Inc. Implant device for trans myocardial revascularization
US6042581A (en) 1996-11-08 2000-03-28 Thomas J. Fogarty Transvascular TMR device and method
US6010449A (en) * 1997-02-28 2000-01-04 Lumend, Inc. Intravascular catheter system for treating a vascular occlusion
US6508825B1 (en) * 1997-02-28 2003-01-21 Lumend, Inc. Apparatus for treating vascular occlusions
US6217549B1 (en) * 1997-02-28 2001-04-17 Lumend, Inc. Methods and apparatus for treating vascular occlusions
US6026814A (en) * 1997-03-06 2000-02-22 Scimed Life Systems, Inc. System and method for percutaneous coronary artery bypass
US6045565A (en) * 1997-11-04 2000-04-04 Scimed Life Systems, Inc. Percutaneous myocardial revascularization growth factor mediums and method
US6155264A (en) 1997-03-06 2000-12-05 Scimed Life Systems, Inc. Percutaneous bypass by tunneling through vessel wall
US6035856A (en) * 1997-03-06 2000-03-14 Scimed Life Systems Percutaneous bypass with branching vessel
US6093177A (en) 1997-03-07 2000-07-25 Cardiogenesis Corporation Catheter with flexible intermediate section
US5851232A (en) 1997-03-15 1998-12-22 Lois; William A. Venous stent
US5792144A (en) 1997-03-31 1998-08-11 Cathco, Inc. Stent delivery catheter system
US5876373A (en) * 1997-04-04 1999-03-02 Eclipse Surgical Technologies, Inc. Steerable catheter
US5810871A (en) 1997-04-29 1998-09-22 Medtronic, Inc. Stent delivery system
US5891154A (en) * 1997-05-06 1999-04-06 Advanced Cardiovascular System, Inc. Passive perfusion stent delivery system
CN1321619C (en) 1997-05-08 2007-06-20 C·R·巴德有限公司 TMT stent and delivery system
US6443158B1 (en) * 1997-06-19 2002-09-03 Scimed Life Systems, Inc. Percutaneous coronary artery bypass through a venous vessel
US6213126B1 (en) * 1997-06-19 2001-04-10 Scimed Life Systems, Inc. Percutaneous artery to artery bypass using heart tissue as a portion of a bypass conduit
US6071292A (en) 1997-06-28 2000-06-06 Transvascular, Inc. Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures
US5935119A (en) 1997-08-06 1999-08-10 United States Surgical Corporation Perfusion structure
US5908029A (en) 1997-08-15 1999-06-01 Heartstent Corporation Coronary artery bypass with reverse flow
US6027473A (en) 1997-09-05 2000-02-22 Cordis Webster, Inc. Handle for steerable DMR catheter
US5964757A (en) 1997-09-05 1999-10-12 Cordis Webster, Inc. Steerable direct myocardial revascularization catheter
EP0904795A1 (en) 1997-09-05 1999-03-31 Cordis Webster, Inc. Thin-walled catheter with high torsional stiffness
US6402719B1 (en) 1997-09-05 2002-06-11 Cordis Webster, Inc. Steerable DMR catheter with infusion tube
EP0900547B1 (en) 1997-09-05 2007-05-30 Biosense Webster, Inc. Steerable catheter for detecting and revascularizing ischemic myocardial tissue
US5976181A (en) 1997-09-22 1999-11-02 Ave Connaught Balloon mounted stent and method therefor
US6520988B1 (en) 1997-09-24 2003-02-18 Medtronic Ave, Inc. Endolumenal prosthesis and method of use in bifurcation regions of body lumens
US6102941A (en) 1997-10-06 2000-08-15 Heartstent Corporation Transmyocardial implant with coronary ingrowth
US5984956A (en) 1997-10-06 1999-11-16 Heartstent Corporation Transmyocardial implant
US5980548A (en) * 1997-10-29 1999-11-09 Kensey Nash Corporation Transmyocardial revascularization system
US6330884B1 (en) * 1997-11-14 2001-12-18 Transvascular, Inc. Deformable scaffolding multicellular stent
US6197324B1 (en) * 1997-12-18 2001-03-06 C. R. Bard, Inc. System and methods for local delivery of an agent
US6217527B1 (en) * 1998-09-30 2001-04-17 Lumend, Inc. Methods and apparatus for crossing vascular occlusions
US6231546B1 (en) * 1998-01-13 2001-05-15 Lumend, Inc. Methods and apparatus for crossing total occlusions in blood vessels
US6200311B1 (en) * 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6214041B1 (en) * 1998-01-20 2001-04-10 Heartstent Corporation Transmyocardial implant with septal perfusion
US6015405A (en) 1998-01-20 2000-01-18 Tricardia, L.L.C. Device for forming holes in tissue
US6193734B1 (en) * 1998-01-23 2001-02-27 Heartport, Inc. System for performing vascular anastomoses
US7027398B2 (en) * 2001-04-12 2006-04-11 General Instrument Corporation Method and apparatus for monitoring voice conversations from customer premises equipment
US6651670B2 (en) * 1998-02-13 2003-11-25 Ventrica, Inc. Delivering a conduit into a heart wall to place a coronary vessel in communication with a heart chamber and removing tissue from the vessel or heart wall to facilitate such communication
US5989263A (en) 1998-03-11 1999-11-23 Arteria Medical Science L.L.C. Hydraulically actuated dilatation mechanism for vessel dilatation and vascular prosthesis delivery and methods of use
WO1999049910A2 (en) * 1998-03-31 1999-10-07 Transvascular, Inc. Transvascular catheters having imaging transducers
US6029672A (en) 1998-04-20 2000-02-29 Heartstent Corporation Transmyocardial implant procedure and tools
US6076529A (en) 1998-04-20 2000-06-20 Heartstent Corporation Transmyocardial implant with inserted vessel
DE19819629A1 (en) 1998-05-04 1999-11-11 Jomed Implantate Gmbh Radially expandable stent
US6352554B2 (en) 1998-05-08 2002-03-05 Sulzer Vascutek Limited Prosthetic tubular aortic conduit and method for manufacturing the same
US6066169A (en) 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
US5980533A (en) 1998-06-09 1999-11-09 Scimed Life Systems, Inc. Stent delivery system
US6036697A (en) 1998-07-09 2000-03-14 Scimed Life Systems, Inc. Balloon catheter with balloon inflation at distal end of balloon
US20020019629A1 (en) * 1998-07-10 2002-02-14 Medtronic, Inc. Devices, systems and methods for transluminally and controllably forming intramyocardial channels in cardiac tissue
US6171251B1 (en) * 1998-07-14 2001-01-09 Eclipse Surgical Technologies, Inc. Method and apparatus for optimizing direct vessel implants for myocardial revascularization
US6053942A (en) 1998-08-18 2000-04-25 Heartstent Corporation Transmyocardial implant with coronary stent
US6406488B1 (en) * 1998-08-27 2002-06-18 Heartstent Corporation Healing transmyocardial implant
US6139541A (en) 1998-09-02 2000-10-31 Heartstent Corporation Guide for transmyocardial implant
US6254564B1 (en) * 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
EP1112043B1 (en) * 1998-09-10 2006-04-05 Percardia, Inc. Tmr shunt
US6290728B1 (en) * 1998-09-10 2001-09-18 Percardia, Inc. Designs for left ventricular conduit
US6196230B1 (en) * 1998-09-10 2001-03-06 Percardia, Inc. Stent delivery system and method of use
US6261304B1 (en) * 1998-09-10 2001-07-17 Percardia, Inc. Delivery methods for left ventricular conduit
US6641610B2 (en) * 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US5997563A (en) 1998-09-28 1999-12-07 Medtronic, Inc. Implantable stent having variable diameter
US5976155A (en) 1999-03-05 1999-11-02 Advanced Cardiovascular Systems, Inc. System for removably securing a stent on a catheter assembly and method of use
US6126649A (en) 1999-06-10 2000-10-03 Transvascular, Inc. Steerable catheter with external guidewire as catheter tip deflector
US6302892B1 (en) * 1999-08-04 2001-10-16 Percardia, Inc. Blood flow conduit delivery system and method of use
US6253768B1 (en) * 1999-08-04 2001-07-03 Percardia, Inc. Vascular graft bypass
US6113630A (en) 1999-08-13 2000-09-05 Heartstent Corporation Transmyocardial implant with minimized coronary insertion
US6854467B2 (en) * 2000-05-04 2005-02-15 Percardia, Inc. Methods and devices for delivering a ventricular stent
US20020032478A1 (en) * 2000-08-07 2002-03-14 Percardia, Inc. Myocardial stents and related methods of providing direct blood flow from a heart chamber to a coronary vessel
US6632470B2 (en) * 2001-01-31 2003-10-14 Percardia Methods for surface modification
US7008397B2 (en) * 2002-02-13 2006-03-07 Percardia, Inc. Cardiac implant and methods

Cited By (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6694983B2 (en) 1998-09-10 2004-02-24 Percardia, Inc. Delivery methods for left ventricular conduit
US7736327B2 (en) 1998-09-10 2010-06-15 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US7704222B2 (en) 1998-09-10 2010-04-27 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US6610100B2 (en) 1998-09-10 2003-08-26 Percardia, Inc. Designs for left ventricular conduit
US8597226B2 (en) 1998-09-10 2013-12-03 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US6641610B2 (en) 1998-09-10 2003-11-04 Percardia, Inc. Valve designs for left ventricular conduits
US8216174B2 (en) 1998-09-10 2012-07-10 Jenavalve Technology, Inc. Methods and conduits for flowing blood from a heart chamber to a blood vessel
US20030212413A1 (en) * 1999-08-04 2003-11-13 Percardia, Inc. Blood flow conduit delivery system and method of use
US6582444B2 (en) 1999-08-04 2003-06-24 Percardia, Inc. Blood flow conduit delivery system and method of use
US6638237B1 (en) 1999-08-04 2003-10-28 Percardia, Inc. Left ventricular conduits and methods for delivery
US6605113B2 (en) 1999-08-04 2003-08-12 Percardia Inc. Vascular graft bypass
US6605053B1 (en) 1999-09-10 2003-08-12 Percardia, Inc. Conduit designs and related methods for optimal flow control
US20050101903A1 (en) * 2001-08-16 2005-05-12 Percardia, Inc. Interventional diagnostic catheter and a method for using a catheter to access artificial cardiac shunts
US8241346B2 (en) 2001-12-20 2012-08-14 Trivascular, Inc. Endovascular graft and method of delivery
US20090264984A1 (en) * 2001-12-20 2009-10-22 Trivascular2, Inc. Advanced endovascular graft
US8167927B2 (en) 2001-12-20 2012-05-01 Trivascular, Inc. Barbed radially expandable stent
US11439497B2 (en) 2001-12-20 2022-09-13 Trivascular, Inc. Advanced endovascular graft
US10470871B2 (en) 2001-12-20 2019-11-12 Trivascular, Inc. Advanced endovascular graft
US8864814B2 (en) 2001-12-20 2014-10-21 Trivascular, Inc. Method of delivering advanced endovascular graft and system
US8709065B2 (en) 2001-12-20 2014-04-29 Trivascular, Inc. Advanced endovascular graft
US20030216801A1 (en) * 2002-05-17 2003-11-20 Heartstent Corporation Transmyocardial implant with natural vessel graft and method
US11517431B2 (en) 2005-01-20 2022-12-06 Jenavalve Technology, Inc. Catheter system for implantation of prosthetic heart valves
US11357624B2 (en) 2007-04-13 2022-06-14 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10682222B2 (en) 2007-10-04 2020-06-16 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US10245166B2 (en) 2008-02-22 2019-04-02 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US11154398B2 (en) 2008-02-26 2021-10-26 JenaValve Technology. Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US11564794B2 (en) 2008-02-26 2023-01-31 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10993805B2 (en) 2008-02-26 2021-05-04 Jenavalve Technology, Inc. Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient
US10603196B2 (en) 2009-04-28 2020-03-31 Endologix, Inc. Fenestrated prosthesis
US11589981B2 (en) 2010-05-25 2023-02-28 Jenavalve Technology, Inc. Prosthetic heart valve and transcatheter delivered endoprosthesis comprising a prosthetic heart valve and a stent
US10029077B2 (en) 2010-10-18 2018-07-24 Cameron Haery Apparatus and processes for applying substances within mammalian tissue
WO2012054387A3 (en) * 2010-10-18 2012-07-05 Cameron Haery Apparatus and processes for applying substances within mammalian tissue
US9119943B2 (en) 2010-10-18 2015-09-01 Cameron Haery Apparatus and processes for applying substances within mammalian tissue
US20120109279A1 (en) * 2010-11-02 2012-05-03 Endologix, Inc. Apparatus and method of placement of a graft or graft system
US11406518B2 (en) 2010-11-02 2022-08-09 Endologix Llc Apparatus and method of placement of a graft or graft system
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US10226597B2 (en) * 2013-03-07 2019-03-12 Volcano Corporation Guidewire with centering mechanism
US20140257248A1 (en) * 2013-03-07 2014-09-11 Volcano Corporation Guidewire with centering mechanism
US11185405B2 (en) 2013-08-30 2021-11-30 Jenavalve Technology, Inc. Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame
US11337800B2 (en) 2015-05-01 2022-05-24 Jenavalve Technology, Inc. Device and method with reduced pacemaker rate in heart valve replacement
US11129737B2 (en) 2015-06-30 2021-09-28 Endologix Llc Locking assembly for coupling guidewire to delivery system
US11065138B2 (en) 2016-05-13 2021-07-20 Jenavalve Technology, Inc. Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
CN113262380A (en) * 2021-04-21 2021-08-17 温州医科大学附属第一医院 Catheter guiding device in ERCP (percutaneous transluminal coronary angioplasty) operation
WO2023211455A1 (en) * 2022-04-29 2023-11-02 Bard Peripheral Vascular, Inc. Perfusion balloon catheter and related methods

Also Published As

Publication number Publication date
US6196230B1 (en) 2001-03-06
US6409751B1 (en) 2002-06-25
US20040186507A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
US6196230B1 (en) Stent delivery system and method of use
US6261304B1 (en) Delivery methods for left ventricular conduit
US6582444B2 (en) Blood flow conduit delivery system and method of use
US7347867B2 (en) Designs for left ventricular conduit
US8187217B2 (en) TMR shunt
AU764910B2 (en) Placing a guide member into the heart
US7159592B1 (en) Methods and apparatus for transmyocardial direct coronary revascularization
US6605113B2 (en) Vascular graft bypass
US6709415B2 (en) Intraluminal catheter with expandable tubular open-walled element
US8391996B2 (en) Catheter-based tissue remodeling devices and methods
EP1112102A1 (en) Tunneling catheter system for artificial ventricular wall conduit
EP2471492A1 (en) Implantable heart valve
US20130035638A1 (en) Angioplasty assembly
WO2002004064A9 (en) Minimally invasive bypass system and related methods
US20070010781A1 (en) Implantable aorto-coronary sinus shunt for myocardial revascularization
US20070010780A1 (en) Methods of implanting an aorto-coronary sinus shunt for myocardial revascularization
WO2007002616A2 (en) Implantable aorto-coronary sinus shunt for myocardial revascularization and method of usng the same

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: EXPRESSLY ABANDONED -- DURING EXAMINATION